
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Germline Cancer Susceptibility Variants in Patients With Uveal Melanoma - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="67D7138889B732B31C138800343062D9.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334930/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Pigment Cell &amp; Melanoma Research">
<meta name="citation_title" content="Germline Cancer Susceptibility Variants in Patients With Uveal Melanoma">
<meta name="citation_author" content="Pauliina E Repo">
<meta name="citation_author_institution" content="Eye Genetics Group, Folkhälsan Research Center, Helsinki, Finland">
<meta name="citation_author_institution" content="Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland">
<meta name="citation_author" content="Eveliina Jakkula">
<meta name="citation_author_institution" content="Department of Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland">
<meta name="citation_author" content="Juho Hiltunen">
<meta name="citation_author_institution" content="Eye Genetics Group, Folkhälsan Research Center, Helsinki, Finland">
<meta name="citation_author" content="Heidi Putkuri">
<meta name="citation_author_institution" content="Eye Genetics Group, Folkhälsan Research Center, Helsinki, Finland">
<meta name="citation_author" content="Aleksandra Staskiewicz‐Tuikkanen">
<meta name="citation_author_institution" content="Eye Genetics Group, Folkhälsan Research Center, Helsinki, Finland">
<meta name="citation_author" content="Reetta‐Stiina Järvinen">
<meta name="citation_author_institution" content="Eye Genetics Group, Folkhälsan Research Center, Helsinki, Finland">
<meta name="citation_author" content="Martin Täll">
<meta name="citation_author_institution" content="Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland">
<meta name="citation_author" content="Virpi Raivio">
<meta name="citation_author_institution" content="Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland">
<meta name="citation_author" content="Rana&#x27;a T Al‐Jamal">
<meta name="citation_author_institution" content="Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland">
<meta name="citation_author" content="Tero T Kivelä">
<meta name="citation_author_institution" content="Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland">
<meta name="citation_author" content="Joni A Turunen">
<meta name="citation_author_institution" content="Eye Genetics Group, Folkhälsan Research Center, Helsinki, Finland">
<meta name="citation_author_institution" content="Ophthalmic Genetics and Rare Eye Diseases Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland">
<meta name="citation_publication_date" content="2025 Aug 9">
<meta name="citation_volume" content="38">
<meta name="citation_issue" content="5">
<meta name="citation_firstpage" content="e70041">
<meta name="citation_doi" content="10.1111/pcmr.70041">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334930/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334930/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334930/pdf/PCMR-38-0.pdf">
<meta name="description" content="Some patients with uveal melanoma (UM) show genetic cancer predisposition: ~2% harbor a pathogenic or likely pathogenic (P/LP) germline variant in BAP1 or, rarely, in 20 other cancer‐associated genes. Up to 75% of patients with familial UM (FUM) ...">
<meta name="og:title" content="Germline Cancer Susceptibility Variants in Patients With Uveal Melanoma">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Some patients with uveal melanoma (UM) show genetic cancer predisposition: ~2% harbor a pathogenic or likely pathogenic (P/LP) germline variant in BAP1 or, rarely, in 20 other cancer‐associated genes. Up to 75% of patients with familial UM (FUM) ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334930/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12334930">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1111/pcmr.70041"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/PCMR-38-0.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12334930%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12334930/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12334930/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334930/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1111/pcmr.70041" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Pigment Cell Melanoma Res</button></div>. 2025 Aug 9;38(5):e70041. doi: <a href="https://doi.org/10.1111/pcmr.70041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1111/pcmr.70041</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Pigment%20Cell%20Melanoma%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pigment%20Cell%20Melanoma%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Pigment%20Cell%20Melanoma%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Pigment%20Cell%20Melanoma%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Germline Cancer Susceptibility Variants in Patients With Uveal Melanoma</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Repo%20PE%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Pauliina E Repo</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Pauliina E Repo</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Eye Genetics Group, Folkhälsan Research Center, Helsinki, Finland</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Repo%20PE%22%5BAuthor%5D" class="usa-link"><span class="name western">Pauliina E Repo</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jakkula%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Eveliina Jakkula</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Eveliina Jakkula</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Department of Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jakkula%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Eveliina Jakkula</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hiltunen%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Juho Hiltunen</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Juho Hiltunen</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Eye Genetics Group, Folkhälsan Research Center, Helsinki, Finland</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hiltunen%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Juho Hiltunen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Putkuri%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Heidi Putkuri</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Heidi Putkuri</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Eye Genetics Group, Folkhälsan Research Center, Helsinki, Finland</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Putkuri%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Heidi Putkuri</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Staskiewicz%E2%80%90Tuikkanen%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Aleksandra Staskiewicz‐Tuikkanen</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Aleksandra Staskiewicz‐Tuikkanen</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Eye Genetics Group, Folkhälsan Research Center, Helsinki, Finland</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Staskiewicz%E2%80%90Tuikkanen%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aleksandra Staskiewicz‐Tuikkanen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%C3%A4rvinen%20RS%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Reetta‐Stiina Järvinen</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Reetta‐Stiina Järvinen</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Eye Genetics Group, Folkhälsan Research Center, Helsinki, Finland</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%C3%A4rvinen%20RS%22%5BAuthor%5D" class="usa-link"><span class="name western">Reetta‐Stiina Järvinen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22T%C3%A4ll%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Martin Täll</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Martin Täll</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22T%C3%A4ll%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Martin Täll</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Raivio%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Virpi Raivio</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Virpi Raivio</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Raivio%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Virpi Raivio</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Al%E2%80%90Jamal%20RT%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Rana'a T Al‐Jamal</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Rana'a T Al‐Jamal</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Al%E2%80%90Jamal%20RT%22%5BAuthor%5D" class="usa-link"><span class="name western">Rana'a T Al‐Jamal</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kivel%C3%A4%20TT%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Tero T Kivelä</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Tero T Kivelä</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kivel%C3%A4%20TT%22%5BAuthor%5D" class="usa-link"><span class="name western">Tero T Kivelä</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Turunen%20JA%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Joni A Turunen</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Joni A Turunen</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Eye Genetics Group, Folkhälsan Research Center, Helsinki, Finland</div>
<div class="p">
<sup>
<sup>4</sup>
</sup>Ophthalmic Genetics and Rare Eye Diseases Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Turunen%20JA%22%5BAuthor%5D" class="usa-link"><span class="name western">Joni A Turunen</span></a>
</div>
</div>
<sup>1,</sup><sup>4</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="pcmr70041-aff-0001">
<sup>
<sup>1</sup>
</sup>Eye Genetics Group, Folkhälsan Research Center, Helsinki, Finland</div>
<div id="pcmr70041-aff-0002">
<sup>
<sup>2</sup>
</sup>Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland</div>
<div id="pcmr70041-aff-0003">
<sup>
<sup>3</sup>
</sup>Department of Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland</div>
<div id="pcmr70041-aff-0004">
<sup>
<sup>4</sup>
</sup>Ophthalmic Genetics and Rare Eye Diseases Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Pauliina E. Repo (<span>pauliina.e.repo@helsinki.fi</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jun 16; Received 2025 Mar 3; Accepted 2025 Jul 20; Issue date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Pigment Cell &amp; Melanoma Research</em> published by John Wiley &amp; Sons Ltd.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by-nc/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12334930</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<p>Some patients with uveal melanoma (UM) show genetic cancer predisposition: ~2% harbor a pathogenic or likely pathogenic (P/LP) germline variant in <em>BAP1</em> or, rarely, in 20 other cancer‐associated genes. Up to 75% of patients with familial UM (FUM) lack genetic diagnosis, prompting a search beyond <em>BAP1</em>. We studied with exome sequencing blood samples from 106 patients with UM and higher‐than‐average risk of cancer (UM ≤ 45 years of age, bilateral or familial UM, or personal history of non‐ocular cancer) and no P/LP variants in <em>BAP1</em>. Sixteen (15%; 95% confidence interval [CI] 9–23) patients carried at least one P/LP variant in dominant cancer genes (<em>CHEK2</em>, <em>DDX41</em>, <em>FANCM</em>, <em>HOXB13</em>, <em>RAD50</em>, <em>SDHA, SDHB</em>) and fifteen in recessive ones. Only <em>CHEK2</em> and <em>FANCM</em> have previously been reported in patients with UM. Six patients (6%; 95% CI 2–12) carried multilocus P/LP variants. Their median age at diagnosis of UM was 51 (range, 22–69) years, 9 years less than the cohort median of 60 (range, 13–89). This suggests a role for co‐occurring pathogenic variants and potentially multilocus inherited neoplasia allele syndrome (MINAS) in UM predisposition. None with FUM carried P/LP variants, warranting investigation of further genes, lower penetrance variants, and multi‐gene heterozygosity in UM predisposition.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> BAP1, cancer predisposition, cancer syndrome, double heterozygosity, MINAS, multi‐locus, uveal melanoma</p></section></section><section class="abstract" id="abstract2"><hr class="headless">
<p>Germline exome sequencing of 106 Finnish patients with UM, considered at higher risk for genetic cancer predisposition, identified pathogenic or likely pathogenic variants associated with varying risk of malignancies in 16 patients (15%). Six patients (6%) carried multiple variants and had a median diagnosis age of 51, compared to 60 in the full cohort and 65 in a larger consecutive series.</p>
<section class="bt xbox font-sm" id="pcmr70041-blkfxd-0001"><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9a/12334930/e0d0dcee1cfa/PCMR-38-0-g001.jpg" loading="lazy" id="jats-graphic-1" height="232" width="331" alt="graphic file with name PCMR-38-0-g001.jpg"></p></section></section><hr class="headless">
<section class="bt xbox font-sm" id="pcmr70041-blkfxd-1001"><h2 class="obj_head">Summary.</h2>
<ul id="pcmr70041-list-1001" class="list" style="list-style-type:disc">
<li id="pcmr70041-li-0001"><p>We studied with exome sequencing106 Finnish patients with uveal melanoma (UM) for pathogenic germline variants in cancer‐associated genes.</p></li>
<li id="pcmr70041-li-1002"><p>Patient selection criteria included UM ≤ 45 years of age, bilateral or familial UM, or other non‐ocular cancer.</p></li>
<li id="pcmr70041-li-1003"><p>Sixteen (15%; 95% confidence interval [CI] 9–23) carried pathogenic or likely pathogenic variants in dominant cancer genes, including <em>CHEK2</em>, <em>DDX41</em>, <em>FANCM</em>, <em>HOXB13</em>, <em>RAD50</em>, <em>SDHA</em>, and <em>SDHB</em>.</p></li>
<li id="pcmr70041-li-1004"><p>Six (6%; 95% CI 2–12) carried two or more variants in dominant and/or recessive cancer genes and developed UM 9 years earlier than the cohort median of 60 (range 13–89), suggesting a potential role for multiple co‐occurring variants in UM pathogenesis.</p></li>
</ul></section><section id="pcmr70041-sec-0003"><p>In 12% of patients with uveal melanoma (UM), the most common primary intraocular cancer in adults, personal or family cancer history suggests possible cancer predisposition (Abdel‐Rahman et al. <a href="#pcmr70041-bib-0001" class="usa-link" aria-describedby="pcmr70041-bib-0001"><sup>2010</sup></a>), and 1%–4% of all patients report familial UM (FUM) (Abdel‐Rahman et al. <a href="#pcmr70041-bib-0001" class="usa-link" aria-describedby="pcmr70041-bib-0001"><sup>2010</sup></a>; Singh et al. <a href="#pcmr70041-bib-0059" class="usa-link" aria-describedby="pcmr70041-bib-0059"><sup>1996</sup></a>; Repo et al. <a href="#pcmr70041-bib-0051" class="usa-link" aria-describedby="pcmr70041-bib-0051"><sup>2019</sup></a>). <em>BAP1</em> is the only high‐penetrance UM susceptibility gene identified to date, and pathogenic (P) or likely pathogenic (LP) variants in <em>BAP1</em> are identified in 2% of all patients with UM and up to one‐quarter of those with FUM (Abdel‐Rahman et al. <a href="#pcmr70041-bib-0001" class="usa-link" aria-describedby="pcmr70041-bib-0001"><sup>2010</sup></a>; Repo et al. <a href="#pcmr70041-bib-0051" class="usa-link" aria-describedby="pcmr70041-bib-0051"><sup>2019</sup></a>; Gupta et al. <a href="#pcmr70041-bib-0019" class="usa-link" aria-describedby="pcmr70041-bib-0019"><sup>2015</sup></a>; Rai et al. <a href="#pcmr70041-bib-0049" class="usa-link" aria-describedby="pcmr70041-bib-0049"><sup>2017</sup></a>). The dominant BAP1 tumor predisposition syndrome (BAP1‐TPDS) predisposes individuals to several cancers in addition to UM, including especially mesothelioma, cutaneous melanoma (CM), and renal cell carcinoma (RCC), and possibly less frequently to several other cancers (Carbone et al. <a href="#pcmr70041-bib-0008" class="usa-link" aria-describedby="pcmr70041-bib-0008">2022</a>; Pilarski et al. <a href="#pcmr70041-bib-0046" class="usa-link" aria-describedby="pcmr70041-bib-0046"><sup>2016</sup></a>; Albright et al. <a href="#pcmr70041-bib-0003" class="usa-link" aria-describedby="pcmr70041-bib-0003"><sup>2023</sup></a>; Prasad et al. <a href="#pcmr70041-bib-0048" class="usa-link" aria-describedby="pcmr70041-bib-0048"><sup>2021</sup></a>).</p>
<p>Aside from <em>BAP1</em>, isolated patients with UM have so far been reported to carry P/LP germline variants in 20 genes associated with a dominant risk of various cancers (Cruz et al. <a href="#pcmr70041-bib-0009" class="usa-link" aria-describedby="pcmr70041-bib-0009">2011</a>; Johansson et al. <a href="#pcmr70041-bib-0026" class="usa-link" aria-describedby="pcmr70041-bib-0026"><sup>2025</sup></a>; Repo et al. <a href="#pcmr70041-bib-0052" class="usa-link" aria-describedby="pcmr70041-bib-0052"><sup>2024</sup></a>; Palles et al. <a href="#pcmr70041-bib-0045" class="usa-link" aria-describedby="pcmr70041-bib-0045"><sup>2022</sup></a>; Iscovich et al. <a href="#pcmr70041-bib-0025" class="usa-link" aria-describedby="pcmr70041-bib-0025"><sup>2002</sup></a>; Sinilnikova et al. <a href="#pcmr70041-bib-0060" class="usa-link" aria-describedby="pcmr70041-bib-0060"><sup>1999</sup></a>; Huang et al. <a href="#pcmr70041-bib-0024" class="usa-link" aria-describedby="pcmr70041-bib-0024"><sup>2018</sup></a>; Abdel‐Rahman et al. <a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002"><sup>2020</sup></a>; Hajkova et al. <a href="#pcmr70041-bib-0020" class="usa-link" aria-describedby="pcmr70041-bib-0020"><sup>2018</sup></a>; Lobo et al. <a href="#pcmr70041-bib-0037" class="usa-link" aria-describedby="pcmr70041-bib-0037"><sup>2017</sup></a>; Hearle et al. <a href="#pcmr70041-bib-0022" class="usa-link" aria-describedby="pcmr70041-bib-0022"><sup>2003</sup></a>; Kannengiesser et al. <a href="#pcmr70041-bib-0028" class="usa-link" aria-describedby="pcmr70041-bib-0028"><sup>2003</sup></a>; Fontcuberta et al. <a href="#pcmr70041-bib-0015" class="usa-link" aria-describedby="pcmr70041-bib-0015"><sup>2011</sup></a>; Nathan et al. <a href="#pcmr70041-bib-0043" class="usa-link" aria-describedby="pcmr70041-bib-0043"><sup>2021</sup></a>; Derrien et al. <a href="#pcmr70041-bib-0012" class="usa-link" aria-describedby="pcmr70041-bib-0012"><sup>2021</sup></a>; Johansson et al. <a href="#pcmr70041-bib-0027" class="usa-link" aria-describedby="pcmr70041-bib-0027"><sup>2019</sup></a>; Rodrigues et al. <a href="#pcmr70041-bib-0055" class="usa-link" aria-describedby="pcmr70041-bib-0055"><sup>2018</sup></a>). One percent of French patients harbor a protein‐truncating germline variant in <em>MBD4</em>, linked to a recessive tumor predisposition syndrome characterized by acute myeloid leukemia, colorectal adenomatous polyposis, and UM (Palles et al. <a href="#pcmr70041-bib-0045" class="usa-link" aria-describedby="pcmr70041-bib-0045">2022</a>; Derrien et al. <a href="#pcmr70041-bib-0012" class="usa-link" aria-describedby="pcmr70041-bib-0012"><sup>2021</sup></a>; Villy et al. <a href="#pcmr70041-bib-0068" class="usa-link" aria-describedby="pcmr70041-bib-0068"><sup>2023</sup></a>). Additionally, heterozygous French carriers are reported to have a 9.15‐fold increased risk of developing UM (Derrien et al. <a href="#pcmr70041-bib-0012" class="usa-link" aria-describedby="pcmr70041-bib-0012">2021</a>). Patients with <em>MBD4</em> loss benefit from treatment with immune checkpoint inhibitors, making their identification important for patient care (Johansson et al. <a href="#pcmr70041-bib-0027" class="usa-link" aria-describedby="pcmr70041-bib-0027">2019</a>; Rodrigues et al. <a href="#pcmr70041-bib-0055" class="usa-link" aria-describedby="pcmr70041-bib-0055"><sup>2018</sup></a>; Saint‐Ghislain et al. <a href="#pcmr70041-bib-0056" class="usa-link" aria-describedby="pcmr70041-bib-0056"><sup>2022</sup></a>). Of the remaining 19 genes (Table <a href="#pcmr70041-tbl-0001" class="usa-link">1</a>), further evidence for a role in predisposition to UM exists for <em>CDKN2A</em>, <em>MLH1, MSH6</em>, and <em>PALB2</em> based on their inactivation in UM or its metastases (Huang et al. <a href="#pcmr70041-bib-0024" class="usa-link" aria-describedby="pcmr70041-bib-0024">2018</a>; Abdel‐Rahman et al. <a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002"><sup>2020</sup></a>; Lobo et al. <a href="#pcmr70041-bib-0037" class="usa-link" aria-describedby="pcmr70041-bib-0037"><sup>2017</sup></a>; Kannengiesser et al. <a href="#pcmr70041-bib-0028" class="usa-link" aria-describedby="pcmr70041-bib-0028"><sup>2003</sup></a>; Derrien et al. <a href="#pcmr70041-bib-0012" class="usa-link" aria-describedby="pcmr70041-bib-0012"><sup>2021</sup></a>; Johansson et al. <a href="#pcmr70041-bib-0027" class="usa-link" aria-describedby="pcmr70041-bib-0027"><sup>2019</sup></a>; Rodrigues et al. <a href="#pcmr70041-bib-0055" class="usa-link" aria-describedby="pcmr70041-bib-0055"><sup>2018</sup></a>). Details of the numerous <em>BAP1</em> and <em>MBD4</em> variants have been summarized in previous publications (Carbone et al. <a href="#pcmr70041-bib-0008" class="usa-link" aria-describedby="pcmr70041-bib-0008">2022</a>; Derrien et al. <a href="#pcmr70041-bib-0012" class="usa-link" aria-describedby="pcmr70041-bib-0012"><sup>2021</sup></a>; Villy et al. <a href="#pcmr70041-bib-0068" class="usa-link" aria-describedby="pcmr70041-bib-0068"><sup>2023</sup></a>). Moreover, three carriers of two P/LP variants in cancer genes have been reported (Johansson et al. <a href="#pcmr70041-bib-0026" class="usa-link" aria-describedby="pcmr70041-bib-0026">2025</a>; Abdel‐Rahman et al. <a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002"><sup>2020</sup></a>), potentially fitting the new concept of multilocus inherited neoplasia allele syndrome (MINAS) (Whitworth et al. <a href="#pcmr70041-bib-0072" class="usa-link" aria-describedby="pcmr70041-bib-0072">2016</a>; McGuigan et al. <a href="#pcmr70041-bib-0040" class="usa-link" aria-describedby="pcmr70041-bib-0040"><sup>2022</sup></a>).</p>
<section class="tw xbox font-sm" id="pcmr70041-tbl-0001"><h3 class="obj_head">TABLE 1.</h3>
<div class="caption p"><p>Previously published pathogenic (P) and likely pathogenic (LP) germline variants in patients with UM in genes associated with dominant cancer or tumor predisposition.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Gene (transcript)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Common gene associated cancer/tumor risk</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">References</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Variant (ACMG classification)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Propand phenotype, age (sex)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Family cancer history</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Analysis</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Cohort</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">
<em>ATM</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000051.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000051.4</a>)</td>
<td align="center" rowspan="2" valign="top" colspan="1">Breast, ovarian, and colon cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Abdel‐Rahman et al. (<a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002">2020</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.2251‐10T&gt;G (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM, lung cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">None</td>
<td align="center" valign="top" rowspan="1" colspan="1">NGS (30 gene BROCA panel)</td>
<td align="center" valign="top" rowspan="1" colspan="1">154 High risk UM patients (no BAP1)<a href="#pcmr70041-note-0005" class="usa-link">
<sup>a</sup>
</a>
</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Hajkova et al. (<a href="#pcmr70041-bib-0020" class="usa-link" aria-describedby="pcmr70041-bib-0020">2018</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.7010_7065dup Val2355_Ile2356insVal* (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 66 years (F), breast ca 70 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">NGS (panel of 73 genes)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 UM patients with metastatic disease</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<em>ATR</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001184.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_001184.4</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Oropharyngeal and nonmelanoma skin cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Johansson et al. (<a href="#pcmr70041-bib-0026" class="usa-link" aria-describedby="pcmr70041-bib-0026">2025</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.2320dup Ile774Asnfs*3 (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Breast ca 62 years, CM 65 years × 2, UM 67 years, breast ca 68 years (F)</td>
<td align="center" valign="top" rowspan="1" colspan="1">None</td>
<td align="center" valign="top" rowspan="1" colspan="1">WES/WGS (418 genes)</td>
<td align="center" valign="top" rowspan="1" colspan="1">83 patients with UM &amp; CM</td>
</tr>
<tr>
<td align="left" rowspan="3" valign="top" colspan="1">
<em>BRCA1</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>)</td>
<td align="center" rowspan="3" valign="top" colspan="1">Breast and ovarian cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Repo et al. (<a href="#pcmr70041-bib-0052" class="usa-link" aria-describedby="pcmr70041-bib-0052">2024</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.3626del Leu1209* (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 54 years (M)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No UM</td>
<td align="center" valign="top" rowspan="1" colspan="1">NGS (19 UM, BAP1 &amp; RCC associated genes)</td>
<td align="center" valign="top" rowspan="1" colspan="1">270 consecutive UM patients (no BAP1)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Abdel‐Rahman et al. (<a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002">2020</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.2603C&gt;G Ser868* (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM (M), prostate ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">Breast ca, stomach ca, mycosis fungoides, lymphoma, cervical ca, CM, liver ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">NGS (30 gene BROCA panel)</td>
<td align="center" valign="top" rowspan="1" colspan="1">154 High risk UM patients (no BAP1)<a href="#pcmr70041-note-0005" class="usa-link">
<sup>a</sup>
</a>
</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Cruz et al. (<a href="#pcmr70041-bib-0009" class="usa-link" aria-describedby="pcmr70041-bib-0009">2011</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">exon 20 deletion (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 42 years (F), breast ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">Breast ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>BRCA1</em>, <em>BRCA2</em>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">468 <em>BRCA1</em>/<em>2</em>+ carriers</td>
</tr>
<tr>
<td align="left" rowspan="6" valign="top" colspan="1">
<em>BRCA2</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>)</td>
<td align="center" rowspan="6" valign="top" colspan="1">Breast and ovarian cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cruz et al. (<a href="#pcmr70041-bib-0009" class="usa-link" aria-describedby="pcmr70041-bib-0009">2011</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.2701del Ala902Leufs*2 (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 38 years (M), B‐cell lymphoma</td>
<td align="center" valign="top" rowspan="1" colspan="1">Breast ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>BRCA1</em>, <em>BRCA2</em>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">468 <em>BRCA1</em>/<em>2</em>+ carriers</td>
</tr>
<tr>
<td align="center" rowspan="4" valign="top" colspan="1">Iscovich et al. (<a href="#pcmr70041-bib-0025" class="usa-link" aria-describedby="pcmr70041-bib-0025">2002</a>)</td>
<td align="center" rowspan="4" valign="top" colspan="1">c.5946del Ser1982Argfs*22 (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM</td>
<td align="center" valign="top" rowspan="1" colspan="1">Uterine ca</td>
<td align="center" rowspan="4" valign="top" colspan="1">Single variant screening<a href="#pcmr70041-note-0011" class="usa-link">
<sup>g</sup>
</a>
</td>
<td align="center" rowspan="4" valign="top" colspan="1">143 non‐selected UM patients</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">UM</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">UM</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">UM</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Sinilnikova et al. (<a href="#pcmr70041-bib-0060" class="usa-link" aria-describedby="pcmr70041-bib-0060">1999</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.5004del Leu1669* (LP)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 65y (F), breast ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">Pancreatic ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">27 (Sporadic) + 35 (High risk<a href="#pcmr70041-note-0006" class="usa-link">
<sup>b</sup>
</a>) UM patients</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<em>BRIP1</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_032043.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_032043.3</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Ovarian cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Johansson et al. (<a href="#pcmr70041-bib-0026" class="usa-link" aria-describedby="pcmr70041-bib-0026">2025</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>c.2392C&gt;T Arg798* (P)</strong>
<a href="#pcmr70041-note-0010" class="usa-link">
<sup>f</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">CM 47 years, UM 39 years (M)</td>
<td align="center" valign="top" rowspan="1" colspan="1">CM, mucosal melanoma, astrocytoma, thyroid ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">WES/WGS (418 genes)</td>
<td align="center" valign="top" rowspan="1" colspan="1">83 patients with UM &amp; CM</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">
<strong>
<em>CDKN2A</em>
</strong> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000077.5" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000077.5</a>)</td>
<td align="center" rowspan="2" valign="top" colspan="1">Cutaneous melanoma and pancreatic cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Hearle et al. (<a href="#pcmr70041-bib-0022" class="usa-link" aria-describedby="pcmr70041-bib-0022">2003</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.104G&gt;C Gly35Ala (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 59 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">No CM or UM</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>BRCA2, CDKN2A, CDKN2B</em>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">385 non‐selected UM patients</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Kannengiesser et al. (<a href="#pcmr70041-bib-0028" class="usa-link" aria-describedby="pcmr70041-bib-0028">2003</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>c.199G&gt;A Gly67Ser (LP)</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 47 years (M)</td>
<td align="center" valign="top" rowspan="1" colspan="1">CM, nodular CM</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>CDKN2A</em>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Case report</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">
<em>CHEK2</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007194.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007194.4</a>)</td>
<td align="center" rowspan="2" valign="top" colspan="1">Breast, prostate, and colorectal cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Abdel‐Rahman et al. (<a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002">2020</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.1100delC Thr367Metfs*15 (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 49 years (F), RCC, BCC</td>
<td align="center" valign="top" rowspan="1" colspan="1">CM, breast ca, prostate ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">WES</td>
<td align="center" valign="top" rowspan="1" colspan="1">154 High risk UM patients (no BAP1)<a href="#pcmr70041-note-0005" class="usa-link">
<sup>a</sup>
</a>
</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Abdel‐Rahman et al. (<a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002">2020</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.470T&gt;C Ile157Thr (LB)<a href="#pcmr70041-note-0007" class="usa-link">
<sup>
c
</sup>
</a><sup>, </sup><a href="#pcmr70041-note-0008" class="usa-link">
<sup>
d
</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 51 years (M)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Breast ca, pancreatic ca, colon ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">NGS (30 gene BROCA panel)</td>
<td align="center" valign="top" rowspan="1" colspan="1">154 High risk UM patients (no BAP1)<a href="#pcmr70041-note-0005" class="usa-link">
<sup>a</sup>
</a>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<em>CTNNA1</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001903.5" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_001903.5</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gastric and breast cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Abdel‐Rahman et al. (<a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002">2020</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.1078_1081del Arg360Valfs*8 (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM</td>
<td align="center" valign="top" rowspan="1" colspan="1">None</td>
<td align="center" valign="top" rowspan="1" colspan="1">NGS (30 gene BROCA panel)</td>
<td align="center" valign="top" rowspan="1" colspan="1">154 High risk UM patients (no BAP1)<a href="#pcmr70041-note-0005" class="usa-link">
<sup>a</sup>
</a>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<em>FANCD2</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001018115.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_001018115.3</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Breast cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Huang et al. (<a href="#pcmr70041-bib-0024" class="usa-link" aria-describedby="pcmr70041-bib-0024">2018</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.2380C&gt;T Arg794* (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 78 years (F)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">WES/WGS</td>
<td align="center" valign="top" rowspan="1" colspan="1">80 TCGA patients with enucleated UM</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<em>FANCM</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_020937.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_020937.4</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Breast cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Huang et al. (<a href="#pcmr70041-bib-0024" class="usa-link" aria-describedby="pcmr70041-bib-0024">2018</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.636dup Ile213Tyrfs*2 (LP)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 57 years (M)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">WES/WGS</td>
<td align="center" valign="top" rowspan="1" colspan="1">80 TCGA patients with enucleated UM</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<em>FLCN</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_144997.7" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_144997.7</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Renal cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Fontcuberta et al. (<a href="#pcmr70041-bib-0015" class="usa-link" aria-describedby="pcmr70041-bib-0015">2011</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.1285del His429Thrfs*39 (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 63 years (M), bilateral multifocal renal tumors (chromophobe cell ca, oncocytomas), liver cysts, facial fibrofolliculomas</td>
<td align="center" valign="top" rowspan="1" colspan="1">None</td>
<td align="center" valign="top" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="top" rowspan="1" colspan="1">Case report</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<em>MET</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000245.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000245.4</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Renal cell carcinoma</td>
<td align="center" valign="top" rowspan="1" colspan="1">Repo et al. (<a href="#pcmr70041-bib-0052" class="usa-link" aria-describedby="pcmr70041-bib-0052">2024</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.252C&gt;G Tyr84* (LP)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 54 years (M)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">NGS (19 UM, BAP1 &amp; RCC associated genes)</td>
<td align="center" valign="top" rowspan="1" colspan="1">270 consecutive UM patients (no BAP1)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<em>MITF</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000248.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000248.4</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cutaneous melanoma</td>
<td align="center" valign="top" rowspan="1" colspan="1">Johansson et al. (<a href="#pcmr70041-bib-0026" class="usa-link" aria-describedby="pcmr70041-bib-0026">2025</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.952G&gt;A Glu318Lys (LP)</td>
<td align="center" valign="top" rowspan="1" colspan="1">CM 51 years ×2, CM 65 years, UM 65 years (F)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Colorectal ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">WES/WGS (418 genes)</td>
<td align="center" valign="top" rowspan="1" colspan="1">83 patients with UM &amp; CM</td>
</tr>
<tr>
<td align="left" rowspan="3" valign="top" colspan="1">
<strong>
<em>MLH1</em>
</strong> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000249.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000249.4</a>)</td>
<td align="center" rowspan="3" valign="top" colspan="1">Colorectal, gastrointestinal, urological, ovarian, endometrial cancers</td>
<td align="center" valign="top" rowspan="1" colspan="1">Abdel‐Rahman et al. (<a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002">2020</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>c.200G&gt;A Gly67Glu (P)</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 49 years (F), breast ca 39 years, sebaceous ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM, colon ca, CM, bladder ca, prostate ca, Hodgkin's lymphoma</td>
<td align="center" valign="top" rowspan="1" colspan="1">WES</td>
<td align="center" valign="top" rowspan="1" colspan="1">154 High risk UM patients (no BAP1)<a href="#pcmr70041-note-0005" class="usa-link">
<sup>a</sup>
</a>
</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Huang et al. (<a href="#pcmr70041-bib-0024" class="usa-link" aria-describedby="pcmr70041-bib-0024">2018</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>c.52C&gt;T Arg18Cys (LP)</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 74 years (M)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">WES/WGS</td>
<td align="center" valign="top" rowspan="1" colspan="1">80 TCGA patients with enucleated UM</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Lobo et al. (<a href="#pcmr70041-bib-0037" class="usa-link" aria-describedby="pcmr70041-bib-0037">2017</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>c.665del Asn222Metfs*7 (P)</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 25 years (F), endometrial and endometroid ca 47 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">Lynch syndrome (colon, endometrial, prostate ca)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>MLH1</em> c.665del testing</td>
<td align="center" valign="top" rowspan="1" colspan="1">Case report</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">
<strong>
<em>MSH6</em>
</strong> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000179.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000179.3</a>)</td>
<td align="center" rowspan="4" valign="top" colspan="1">Lynch syndrome (Colorectal, gastrointestinal, urological, female reproductive tracts cancers)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Abdel‐Rahman et al. (<a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002">2020</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.2731C&gt;T Arg911* (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM (F), endometrial, BCC, SCC</td>
<td align="center" valign="top" rowspan="1" colspan="1">Lynch syndrome</td>
<td align="center" valign="top" rowspan="1" colspan="1">NGS (30 gene BROCA panel)</td>
<td align="center" valign="top" rowspan="1" colspan="1">154 High risk UM patients (no BAP1)<a href="#pcmr70041-note-0005" class="usa-link">
<sup>a</sup>
</a>
</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Abdel‐Rahman et al. (<a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002">2020</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>c.3495C&gt;G Cys1165Trp (LP)</strong>
<a href="#pcmr70041-note-0009" class="usa-link">
<sup>
<strong>e</strong>
</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 46 years (F), endometrial ca 51 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM, non‐melanoma skin ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">WES</td>
<td align="center" valign="top" rowspan="1" colspan="1">154 High risk UM patients (no BAP1)<a href="#pcmr70041-note-0005" class="usa-link">
<sup>a</sup>
</a>
</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Johansson et al. (<a href="#pcmr70041-bib-0026" class="usa-link" aria-describedby="pcmr70041-bib-0026">2025</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>c.3226C&gt;T p.(Arg1076Cys) (P)</strong>
<a href="#pcmr70041-note-0010" class="usa-link">
<sup>f</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">CM 47 years, UM 39 years (M)</td>
<td align="center" valign="top" rowspan="1" colspan="1">CM, mucosal melanoma, astrocytoma, thyroid ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">WES/WGS (418 genes)</td>
<td align="center" valign="top" rowspan="1" colspan="1">83 patients with UM &amp; CM</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Johansson et al. (<a href="#pcmr70041-bib-0026" class="usa-link" aria-describedby="pcmr70041-bib-0026">2025</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.3226C&gt;T p.(Arg1076Cys) (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">CM 65 years, UM 72 years, lymphoma 76 years (M)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Glioblastoma multiforme, testicular ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">WES/WGS (418 genes)</td>
<td align="center" valign="top" rowspan="1" colspan="1">83 patients with UM &amp; CM</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<em>NBN</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_002485.5" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_002485.5</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Breast and prostate cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Huang et al. (<a href="#pcmr70041-bib-0024" class="usa-link" aria-describedby="pcmr70041-bib-0024">2018</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.2227_2228del Leu743Phefs*2 (LP)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 60 years (M)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">WES/WGS</td>
<td align="center" valign="top" rowspan="1" colspan="1">80 TCGA patients with enucleated UM</td>
</tr>
<tr>
<td align="left" rowspan="3" valign="top" colspan="1">
<strong>
<em>PALB2</em>
</strong> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_024675.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_024675.4</a>)</td>
<td align="center" rowspan="3" valign="top" colspan="1">Breast and ovarian cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Abdel‐Rahman et al. (<a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002">2020</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.49‐1G&gt;A (P)<a href="#pcmr70041-note-0008" class="usa-link">
<sup>d</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 51 years (M)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Breast ca, pancreatic ca, colon ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">NGS (30 gene BROCA panel)</td>
<td align="center" valign="top" rowspan="1" colspan="1">154 High risk UM patients (no BAP1)<a href="#pcmr70041-note-0005" class="usa-link">
<sup>a</sup>
</a>
</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Abdel‐Rahman et al. (<a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002">2020</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.3113G&gt;A Trp1038* (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 62y (F), breast ca 36 years, breast ca 56 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">Breast ca (M)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>PALB2</em>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Database of <em>PALB2</em> variant carriers</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Abdel‐Rahman et al. (<a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002">2020</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>c.3201+1G&gt;C (P)</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 67 years (F), RCC 67 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM</td>
<td align="center" valign="top" rowspan="1" colspan="1">WES</td>
<td align="center" valign="top" rowspan="1" colspan="1">154 High risk UM patients (no BAP1)<a href="#pcmr70041-note-0005" class="usa-link">
<sup>a</sup>
</a>
</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">
<em>POT1</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_015450.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_015450.3</a>)</td>
<td align="center" rowspan="2" valign="top" colspan="1">Glioma, cutaneous melanoma, chronic lymphocytic leukaemia, thyroid and colorectal cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Huang et al. (<a href="#pcmr70041-bib-0024" class="usa-link" aria-describedby="pcmr70041-bib-0024">2018</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.258dup Gln87Leufs* (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 51 years (F)</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">WES/WGS</td>
<td align="center" valign="top" rowspan="1" colspan="1">80 TCGA patients with enucleated UM</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Nathan et al. (<a href="#pcmr70041-bib-0043" class="usa-link" aria-describedby="pcmr70041-bib-0043">2021</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.281_282del Gln94Argfs*13 (P)</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 57 years, CM 65 years, CM 68 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">Liver, ovarian, pancreatic, genital ca, mucosal lentiginous melanoma</td>
<td align="center" valign="top" rowspan="1" colspan="1">WGS</td>
<td align="center" valign="top" rowspan="1" colspan="1">20 patients with UM &amp; CM (no <em>CDKN2A</em>, <em>CDK4</em>, <em>TERT</em>, <em>ACD</em>, <em>TERF2IP</em>, <em>BAP1</em> or <em>MBD4</em>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<em>SMARCE1</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_003079.5" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_003079.5</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Meningioma</td>
<td align="center" valign="top" rowspan="1" colspan="1">Abdel‐Rahman et al. (<a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002">2020</a>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.373G&gt;T Glu125* (LP)<a href="#pcmr70041-note-0009" class="usa-link">
<sup>e</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM 46 years (F), endometrial ca 51 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM, multiple non‐melanoma skin ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">WES</td>
<td align="center" valign="top" rowspan="1" colspan="1">154 High risk UM patients (no BAP1)<a href="#pcmr70041-note-0005" class="usa-link">
<sup>a</sup>
</a>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pcmr70041-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="pcmr70041-note-0003"><p>
<em>Note:</em> The American College of Medical Genetics and Genomics (ACMG) classification (Richards et al. <a href="#pcmr70041-bib-0053" class="usa-link" aria-describedby="pcmr70041-bib-0053">2015</a>) was assigned using Varsome. Only variants interpreted as P/LP, according to present knowledge, are listed. Variant nomenclature may differ from the original publication due to the used transcript. Interpretation may have changed due to alterations in classification guidelines or later information. Genes/variants highlighted in bold are supported by additional evidence of association with primary UM or their metastasis, such as loss of heterozygosity or immunostaining results.</p></div>
<div class="fn" id="pcmr70041-note-0004"><p>Abbreviations: BCC , basal cell carcinoma; CM , cutaneous melanoma; F , female; M , male; NGS , next generation sequencing; RCC , renal cell carcinoma; SCC , squamous cell carcinoma; WES , whole exome sequencing.</p></div>
<div class="fn" id="pcmr70041-note-0005">
<sup>
<sup>a</sup>
</sup><p class="display-inline">WES included 29 patients and BROCA panel (<a href="https://testguide.labmed.uw.edu/public/view/BROCA" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://testguide.labmed.uw.edu/public/view/BROCA</a>) 125 patients, analyzed genes not identical but partly overlapping. High‐risk patients had familial UM, UM diagnosis &lt; 35 years, personal history of other primary cancers, or family history of 2 or more primary cancers.</p>
</div>
<div class="fn" id="pcmr70041-note-0006">
<sup>
<sup>b</sup>
</sup><p class="display-inline">High risk patients had family or personal history of UM, breast or ovarian cancer.</p>
</div>
<div class="fn" id="pcmr70041-note-0007">
<sup>
<sup>c</sup>
</sup><p class="display-inline">A low cancer risk variant, yet likely benign by ACMG.</p>
</div>
<div class="fn" id="pcmr70041-note-0008">
<sup>
<sup>d</sup>
</sup><p class="display-inline">
<em>CHEK2</em> and <em>PALB2</em> variants identified in the same patient.</p>
</div>
<div class="fn" id="pcmr70041-note-0009">
<sup>
<sup>e</sup>
</sup><p class="display-inline">
<em>SMARCE1</em> and MSH6 variants identified in the same patient.</p>
</div>
<div class="fn" id="pcmr70041-note-0010">
<sup>
<sup>f</sup>
</sup><p class="display-inline">
<em>BRIP1</em> and <em>MSH6</em> variants identified in the same patient.</p>
</div>
<div class="fn" id="pcmr70041-note-0011">
<sup>
<sup>g</sup>
</sup><p class="display-inline">Enriched in Ashkenazi Jewish population.</p>
</div>
</div></section><p>The incidence of UM in Europe and North America is about four times as high in Northern than Southern latitudes, including Finland (Kivelä <a href="#pcmr70041-bib-0033" class="usa-link" aria-describedby="pcmr70041-bib-0033">2014</a>), where the frequency of P/LP <em>BAP1</em> variants is no more frequent than elsewhere and where predisposition to FUM remains unresolved for at least 75% of families (Repo et al. <a href="#pcmr70041-bib-0051" class="usa-link" aria-describedby="pcmr70041-bib-0051">2019</a>). To discover further genetic entities predisposing to UM, we performed exome sequencing to analyze cancer‐associated germline variants in Finnish UM patients at higher‐than‐average risk of inherited cancer predisposition but lacking P/LP <em>BAP1</em> germline variants.</p>
<p>Eligible participants were Finnish‐born patients diagnosed with UM in the Ocular Oncology Service, Helsinki University Hospital, a national referral center for eye cancer in Finland, who were (1) ≤ 45 years at the time of UM diagnosis, (2) had a non‐ocular primary cancer before or after UM, (3) bilateral UM, or (4) familial UM. Data on personal and family history of cancer were collected upon enrollment and were available for 521 Finnish patients consecutively diagnosed with UM between 2010 and 2017 (Repo et al. <a href="#pcmr70041-bib-0051" class="usa-link" aria-describedby="pcmr70041-bib-0051">2019</a>). Eleven foreign patients were not eligible. Eight patients with previously identified P/LP germline variants in <em>BAP1</em> were excluded and reported elsewhere (Repo et al. <a href="#pcmr70041-bib-0051" class="usa-link" aria-describedby="pcmr70041-bib-0051">2019</a>; Turunen et al. <a href="#pcmr70041-bib-0065" class="usa-link" aria-describedby="pcmr70041-bib-0065"><sup>2016</sup></a>). Altogether, 92 patients met our enrollment criteria, were willing to participate, and had donated a sample at the time of the study. Additionally, 14 Finnish patients diagnosed with UM before 2010 or after 2017 were enrolled based on UM diagnosed at &lt; 25 years of age, familial UM, or additional diagnosis of RCC, the most frequent of the non‐ocular cancers associated with BAP1‐TPDS (Repo et al. <a href="#pcmr70041-bib-0052" class="usa-link" aria-describedby="pcmr70041-bib-0052">2024</a>). The cohort overlaps with cohorts of previous studies (Figure <a href="#pcmr70041-supitem-0001" class="usa-link">S1</a>). The project was approved by the institutional review board of the Hospital Region of Helsinki and Uusimaa on June 11, 2012, and it followed the tenets of the Declaration of Helsinki. Written informed consent was given by all patients who were eligible and chose to participate in the study.</p>
<p>Genomic DNA from the 106 enrolled high‐risk patients was extracted from peripheral whole blood using standard methods. Libraries were prepared using either the Twist EF kit with Twist Core Exome kit (both from Twist Bioscience, San Francisco, CA) or Kapa Hyper Sample Prep with NimbleGen SeqCap EZ MedExome kit (both from Roche Nimblegen, WI) and sequenced on Illumina HiSeq or NovaSeq platforms (San Diego, CA). Exome sequencing, read alignment to Genome Reference Consortium Human Build 37 (GRCh37) and variant calling were performed by the Institute for Molecular Medicine Finland (FIMM, Helsinki, Finland) (Sulonen et al. <a href="#pcmr70041-bib-0063" class="usa-link" aria-describedby="pcmr70041-bib-0063">2011</a>). Variants were annotated with Annotate Variation (ANNOVAR) (Wang et al. <a href="#pcmr70041-bib-0070" class="usa-link" aria-describedby="pcmr70041-bib-0070">2010</a>).</p>
<p>We selected 241 genes associated with BAP1, UM, or other cancers for analysis (Table <a href="#pcmr70041-supitem-0001" class="usa-link">S1</a>). Gene selection was done using literature, Genomics England PanelApp available at <a href="https://panelapp.genomicsengland.co.uk/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://panelapp.genomicsengland.co.uk/</a>, the STRING database (Szklarczyk et al. <a href="#pcmr70041-bib-0064" class="usa-link" aria-describedby="pcmr70041-bib-0064">2019</a>), and the Cancer Gene Census database (Sondka et al. <a href="#pcmr70041-bib-0061" class="usa-link" aria-describedby="pcmr70041-bib-0061">2018</a>). Variants with read depth less than 10 and variant allele frequency (VAF) &lt; 30% were excluded. Variants reported as P/LP in ClinVar and nonsynonymous variants with MAF &lt; 0.001 in gnomAD v2.1.1 (Karczewski et al. <a href="#pcmr70041-bib-0029" class="usa-link" aria-describedby="pcmr70041-bib-0029">2020</a>) predicted as deleterious by MetaRNN (Li et al. <a href="#pcmr70041-bib-0036" class="usa-link" aria-describedby="pcmr70041-bib-0036">2022</a>) were included unless reported as benign or likely benign. VarSome (Kopanos et al. <a href="#pcmr70041-bib-0034" class="usa-link" aria-describedby="pcmr70041-bib-0034">2019</a>) was used to assign the American College of Medical Genetics and Genomics (ACMG) classifications (Richards et al. <a href="#pcmr70041-bib-0053" class="usa-link" aria-describedby="pcmr70041-bib-0053">2015</a>) to the remaining variants. Variants in tables 2–3 were inspected manually with Integrative Genomics Viewer (IGV) (Robinson et al. <a href="#pcmr70041-bib-0054" class="usa-link" aria-describedby="pcmr70041-bib-0054">2011</a>). RStudio version 2025.05.0 (build 496) was used to calculate odds ratios for pathogenic and likely pathogenic variants occurring in multiple individuals by comparing UM cohort data to the Finnish gnomAD v2.1.1 cohort by Fisher's Exact Test for Count Data. Carrier frequency with 95% confidence intervals (CI) was calculated using the modified Wald method.</p>
<p>The median age at diagnosis of the 106 patients with UM who met our criteria for being at higher‐than‐average risk of inherited cancer predisposition was 60 years (range 13–89; Table <a href="#pcmr70041-supitem-0002" class="usa-link">S2</a>). The percentage of patients who were 45 years or younger was 34%, those with FUM 12%, and those with at least one non‐ocular primary malignancy 60%. The most frequent other cancers were prostate (27% of men), breast (31% of women, all affected females), and RCC, typically clear cell type (11%).</p>
<p>Thirteen patients from 10 families had a family history of UM. Among them, 3 had an affected first‐degree relative, whereas 10 had a more distant relative who was affected (cousin, second cousin, or more distant). Three (23%) of them had a history of one non‐ocular primary cancer: two had an RCC, and one had metastatic adenocarcinoma from an unknown primary. Similarly, among the 36 patients 45 years or younger, 3 (8%) had a history of one non‐ocular cancer (CM, thyroid carcinoma, and Hodgkin's disease), and one had bilateral UM (at the age of 42 and 65 years).</p>
<p>Four patients reported a family history of cancers other than UM. A patient with thyroid carcinoma at 49 and UM at 65 reported a sister with breast cancer, another affected by gynecological cancer, and a brother with stomach or pancreatic cancer. Another patient affected by CM at 40, UM at 61, and rectal carcinoma at 65 had a child affected by CM. The third patient with bladder carcinoma at 52 and UM at 69 had a brother deceased of CM, two sisters with unspecified cancers, and an aunt with renal cancer. The fourth had a family history of CM and breast cancer, with no further details available.</p>
<p>We identified P/LP germline variants in dominant cancer‐associated genes in 16 of the 106 patients (15%; 95% confidence interval [CI], 9–23). The variants were found in <em>CHEK2</em> (9 patients), <em>DDX41</em>, <em>FANCM</em> (3 patients), <em>HOXB13</em> (3 patients), <em>RAD50</em> (2 patients), <em>SDHA</em>, and <em>SDHB</em>, linked with varying degrees of dominantly inherited cancer risk (Table <a href="#pcmr70041-tbl-0002" class="usa-link">2</a>). Additionally, 15 patients carried P/LP variants in genes associated with recessive cancer risk, including <em>BLM</em>, <em>CTC1</em> (2 patients), <em>EXO1</em> (2 patients), <em>FANCI</em>, <em>GBA1</em>, <em>NTHL1</em> (2 patients), <em>RECQL4</em>, <em>RMPR</em>, <em>SBDS</em> (3 patients), <em>TRIM37</em>, and <em>WRN</em> (Table <a href="#pcmr70041-tbl-0003" class="usa-link">3</a>). Six patients (6%; 95% CI, 2–12) harbored multiple P/LP variants in dominant (3 patients) or recessive (1 patient) cancer genes, or both (2 patients) (Tables <a href="#pcmr70041-tbl-0002" class="usa-link">2</a> and <a href="#pcmr70041-tbl-0003" class="usa-link">3</a>, Figure <a href="#pcmr70041-supitem-0002" class="usa-link">S2</a>). Identified variants classified as variants of unknown significance (VUS) are listed in Table <a href="#pcmr70041-supitem-0005" class="usa-link">S3</a>.</p>
<section class="tw xbox font-sm" id="pcmr70041-tbl-0002"><h3 class="obj_head">TABLE 2.</h3>
<div class="caption p"><p>Germline variants associated with dominant cancer predisposition among Finnish patients with primary uveal melanoma and higher‐than‐average cancer risk.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Patient</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Patient characteristics</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Sex</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">TNM</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Variant</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">ACMG classification</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">GnomAD v.2.1.1 frequency</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Gene‐disease validity by clingen</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Associated malignancy risk by OMIM</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>UMG06‐55</strong>
</p>
<p>UMG09‐12</p>
<p>
<strong>UMG11‐48</strong>
</p>
<p>UMG12‐26</p>
<p>UMG14‐29</p>
<p>UMG14‐33</p>
<p>UMG15‐25</p>
<p>
<strong>UMG18‐38</strong>
</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<strong>Young UM (22y)</strong>
</p>
<p>UM (60y), RCC, meningioma</p>
<p>
<strong>Young UM (UM 41y)</strong>
</p>
<p>UM (64y), thyroid ca</p>
<p>UM (74y), prostate ca</p>
<p>Young UM (41y)</p>
<p>Young UM (24y)</p>
<p>
<strong>UM (66y), lung carcinoid</strong>
</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<strong>F</strong>
</p>
<p>F</p>
<p>
<strong>F</strong>
</p>
<p>M</p>
<p>M</p>
<p>F</p>
<p>M</p>
<p>
<strong>F</strong>
</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<strong>T3a, stage IIB</strong>
</p>
<p>T2a, stage IIA</p>
<p>
<strong>T2a, stage IIA</strong>
</p>
<p>T2a, stage IIA</p>
<p>T1a, stage I</p>
<p>T4a, stage IIIA</p>
<p>T3a, stage IIB</p>
<p>
<strong>T3a, stage IIB</strong>
</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>CHEK2</em>
</p>
<p>c.470T&gt;C</p>
<p>Ile157Thr</p>
<p>rs17879961</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">LB (BS3, BS1, BP4, PS3, PM1, PM5, PP5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.0049</p>
<p>FIN 0.025</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>AD hereditary breast carcinoma, definitive</p>
<p>AD hereditary nonpolyposis colon cancer, limited</p>
<p>AD, familial ovarian cancer, disputed</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">AD Tumor predisposition syndrome‐4, breast/prostate/colorectal (OMIM 609265), low risk</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<strong>UMG16‐52</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>UM (69y), bladder ca</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>M</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>T2a, stage IIA</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>CHEK2</em>
</p>
<p>c.1100delC</p>
<p>Thr367Metfs*15</p>
<p>rs555607708</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">P (PVS1, PP5, PM2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.0021</p>
<p>FIN 0.0087</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>AD hereditary breast carcinoma, definitive</p>
<p>AD hereditary nonpolyposis colon cancer, limited</p>
<p>AD, familial ovarian cancer, disputed</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">AD Tumor predisposition syndrome‐4, breast/prostate/colorectal (OMIM 609265), moderate risk</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">UMG12‐30</td>
<td align="center" valign="top" rowspan="1" colspan="1">Young UM (41y), thyroid &amp; renal cysts (myotonic dystrophy)</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">T2a stage IIA</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>DDX41</em>
</p>
<p>c.415_418dup</p>
<p>GATG</p>
<p>Asp140Glyfs*2</p>
<p>rs762890562</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">P (PVS1, PP5, PM2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.000081</p>
<p>FIN 0</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">AD DDX41‐related hematologic malignancy predisposition syndrome, definitive</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>AD Myeloproliferative/lymphoproliferative neoplasms</p>
<p>(OMIM 616871), low/moderate risk</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>UMG11‐48</strong>
</p>
<p>UMG13‐07</p>
<p>UMG16‐24</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<strong>Young UM</strong> (<strong>41y</strong>)</p>
<p>UM (80y), prostate ca</p>
<p>UM (74y), prostate ca</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<strong>F</strong>
</p>
<p>M</p>
<p>M</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<strong>T2a, stage IIA</strong>
</p>
<p>T1a, stage I</p>
<p>T1a, stage I</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>FANCM</em>
</p>
<p>c.5101C&gt;T</p>
<p>Gln1701*</p>
<p>rs147021911</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">P (PVS1, PM2, PP5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.0013</p>
<p>FIN 0.0081</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>UMG10‐55</p>
<p>UMG14‐23</p>
<p>
<strong>UMG18‐38</strong>
</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>UM (64y), prostate ca</p>
<p>Young UM (42y, 65y) bilateral</p>
<p>
<strong>UM</strong> (<strong>66y</strong>), <strong>lung carcinoid</strong>
</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>M</p>
<p>M</p>
<p>
<strong>F</strong>
</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>T1a, stage I</p>
<p>T1a, stage I</p>
<p>
<strong>T3a, stage IIB</strong>
</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>HOXB13</em>
</p>
<p>c.251G&gt;A</p>
<p>Gly84Glu</p>
<p>rs138213197</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">LB (BS2, BP4, PP5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.0019</p>
<p>FIN 0.0076</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
<td align="center" valign="top" rowspan="1" colspan="1">AD Prostate cancer (OMIM 610997), low risk</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>UMG14‐31</p>
<p>
<strong>UMG16‐52</strong>
</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>Young UM (44y)</p>
<p>
<strong>UM</strong> (<strong>69y</strong>), <strong>bladder ca</strong>
</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>M</p>
<p>
<strong>M</strong>
</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>T2a, stage IIA</p>
<p>
<strong>T2a, stage IIA</strong>
</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>RAD50</em>
</p>
<p>c.687delT</p>
<p>Ser229Argfs*6</p>
<p>rs760146707</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">P (PVS1, PM2, PP5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.00046</p>
<p>FIN 0.0045</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>AD hereditary breast carcinoma, refuted</p>
<p>AD familial ovarian cancer, refuted</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<strong>UMG14‐24</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>Young UM</strong> (<strong>45y</strong>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>M</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>T3a, stage IIB</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>SDHA</em>
</p>
<p>c.1210C&gt;T</p>
<p>Pro404Ser</p>
<p>rs769936006</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">LP (PP3, PM2, PP2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.000021</p>
<p>FIN 0.000040</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">AD hereditary pheochromocytoma‐paraganglioma, definitive</td>
<td align="center" valign="top" rowspan="1" colspan="1">AD Paragangliomas 5 (OMIM 614165), low risk</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<strong>UMG06‐55</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>Young UM</strong> (<strong>22y</strong>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>F</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>T3a stage IIB</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>SDHB</em>
</p>
<p>c.716_719delCTCT</p>
<p>Ser239Tyrfs*7</p>
<p>rs587781266</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">P (PVS1, PP5, PM2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Not found</td>
<td align="center" valign="top" rowspan="1" colspan="1">AD hereditary pheochromocytoma‐paraganglioma, definitive</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>AD Gastrointestinal stromal tumor (OMIM 606764), high risk</p>
<p>AD Paragangliomas 4 (OMIM 115310), high risk</p>
<p>AD Pheochromocytoma (OMIM 171300), high risk</p>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pcmr70041-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="pcmr70041-note-0012"><p>
<em>Note:</em> Patients identified with more than one pathogenic variant are highlighted in bold. Variants were classified using the American College of Medical Genetics and Genomics guidelines (Richards et al. <a href="#pcmr70041-bib-0053" class="usa-link" aria-describedby="pcmr70041-bib-0053">2015</a>).</p></div>
<div class="fn" id="pcmr70041-note-0013"><p>Abbreviations: ACMG , The American College of Medical Genetics and Genomics; ca , carcinoma; ES , exome sequencing; F , female; FIN , Finnish population; LB , likely benign; LP , likely pathogenic; M , male; <em>P</em> , pathogenic; PM1 , Located in a mutational hot spot and/or critical and well‐established functional domain without benign variation; PM2 , Absent or very rare from race‐matched controls gnomAD; PM5 , Novel missense change at an amino acid residue where a different missense change determined to be pathogenic has been seen before; PP2 , Missense variant in a gene that has a low rate of benign missense variation and in which missense; PP3 , Multiple lines of computational evidence support a deleterious effect; PP5 , Reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation; PS3 , Well‐established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product; PVS1 , Null variant in a gene where loss of function is a known mechanism of disease; RCC , renal cell carcinoma; TAS , targeted amplicon sequencing; TNM , Tumor, Node, Metastasis; UM , uveal melanoma; VAF , variant allele frequency; y , years upon diagnosis.</p></div>
</div></section><section class="tw xbox font-sm" id="pcmr70041-tbl-0003"><h3 class="obj_head">TABLE 3.</h3>
<div class="caption p"><p>Germline variants associated with recessive cancer predisposition among Finnish patients with primary uveal melanoma and higher‐than‐average cancer risk.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Patient</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Patient information</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Sex</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">TNM</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Variant</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">ACMG classification</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">GnomAD v.2.1.1 frequency</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">VAF in cohort</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Gene‐disease validity by clingen</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Associated malignancy risk by OMIM</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<strong>UMG14‐24</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>Young UM (45y)</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>M</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>T3a</strong>, <strong>stage IIB</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>BLM</em>
</p>
<p>c.2824‐2A&gt;T</p>
<p>rs745538883</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">P (PVS1, PM2, PP5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.000011</p>
<p>FIN 0</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0035</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Bloom syndrome, definitive</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Bloom syndrome (OMIM 210900, risk of various cancers at young age)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">UMG15‐04</td>
<td align="center" valign="top" rowspan="1" colspan="1">Young UM (40y)</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">T2a, stage IIA</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>CTC1</em>
</p>
<p>c.1994 T&gt;G</p>
<p>Val665Gly</p>
<p>rs199473676</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">LP (PP5, PM2, BP1, BP4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.00022</p>
<p>FIN 0.0024</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0047</td>
<td align="center" valign="top" rowspan="1" colspan="1">Na</td>
<td align="center" valign="top" rowspan="1" colspan="1">Na</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<strong>UMG16‐52</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>UM (69y), bladder ca</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>M</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>T2a, stage IIA</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>CTC1</em>
</p>
<p>c.3019delC</p>
<p>Leu1007Cysfs*62</p>
<p>rs199473680</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">P (PVS1, PM2, PP5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.00019</p>
<p>FIN 0.0011</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0047</td>
<td align="center" valign="top" rowspan="1" colspan="1">Na</td>
<td align="center" valign="top" rowspan="1" colspan="1">Na</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>UMG03‐06</p>
<p>UMG15‐11</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>UM (61y), RCC</p>
<p>UM (80y), CLL</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>F</p>
<p>M</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>T1a, stage I</p>
<p>T3b, stage IIIA</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>EXO1</em>
</p>
<p>c.2152C&gt;T</p>
<p>Gln718*</p>
<p>rs146594026</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">LP (PVS1, PM2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.00032</p>
<p>FIN 0.0028</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0094</td>
<td align="center" valign="top" rowspan="1" colspan="1">AD Lynch syndrome, refuted</td>
<td align="center" valign="top" rowspan="1" colspan="1">Na</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">UMG14‐37</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM (65y), prostate ca, BCC</td>
<td align="center" valign="top" rowspan="1" colspan="1">M</td>
<td align="center" valign="top" rowspan="1" colspan="1">T1a, stage I</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>FANCI</em>
</p>
<p>c.2957_2969del</p>
<p>Val986Alafs*39</p>
<p>rs762390984</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">LP (PVS1, PM2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.00027</p>
<p>FIN 0.0029</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0047</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Fanconi anemia, definitive</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Fanconi anemia, complementation group I (OMIM 609053, high risk of various cancers)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">UMG13‐67</td>
<td align="center" valign="top" rowspan="1" colspan="1">Young UM (38y), thyroid ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">T3a, stage IIB</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>GBA</em>
</p>
<p>c.1448 T&gt;C</p>
<p>Leu483Pro</p>
<p>rs421016</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>P</p>
<p>(PS3, PM1, PM5, PP5, PM2, BP4)</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.0012</p>
<p>FIN 0.0018</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0047</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Gaucher disease, definitive</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Gaucher disease (OMIM 608013, 230,800, 230,900, 231,000, 231,005, risk of hematological malignancies)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>UMG14‐26</p>
<p>UMG14‐36</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>Young UM (24y)</p>
<p>UM (86y), RCC</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>M</p>
<p>M</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>T3b, stage IIIA</p>
<p>T4a, stage IIIA</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>NTHL1</em>
</p>
<p>c.244C&gt;T</p>
<p>Gln82*</p>
<p>rs150766139</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">P (PVS1, PP5, PM2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.0014</p>
<p>FIN 0.0035</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0094</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>AR NTHL1‐deficiency tumor predisposition syndrome, definitive</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Familial adenomatous polyposis 3 (OMIM 616415, colorectal cancer, carcinomas of other tissues)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<strong>UMG10‐07</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>UM (57y)</strong>, <strong>RCC</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>M</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>T3a, stage IIB</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>RECQL4</em>
</p>
<p>c.1390+2del</p>
<p>rs386833843</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">P (PVS1, PM2, PP5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.00042</p>
<p>FIN 0.0043</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0047</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Rothmund‐Thomson syndrome, definitive</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>AR RAPADILINO syndrome (OMIM 266280, risk of osteosarcoma and others)</p>
<p>AR, Rothmund‐Thomson syndrome type 2 (OMIM 268400, risk of osteosarcoma and others)</p>
<p>AR Baller‐Gerold syndrome (OMIM 218600, increased of osteosarcoma and others)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">UMG90‐02</td>
<td align="center" valign="top" rowspan="1" colspan="1">FUM (58y)</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">T2b, stage IIB</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>RMRP</em>
</p>
<p>n.72A&gt;G</p>
<p>rs199476103</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">LP (PP5, PM2, BP4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.00098</p>
<p>FIN 0.0087</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0047</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Cartilage‐hair hypoplasia, definitive</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Cartilage‐hair hypoplasia (OMIM 250250, increased risk of cancers such as non‐Hodgkin lymphoma and basal cell carcinoma)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>UMG10‐07</strong>
</p>
<p>UMG13‐52</p>
<p>UMG15‐21</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<strong>UM</strong> (<strong>57y</strong>), <strong>RCC</strong>
</p>
<p>Young UM (45y)</p>
<p>UM (62y), prostate ca</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<strong>M</strong>
</p>
<p>F</p>
<p>M</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<strong>T3a, stage IIB</strong>
</p>
<p>T3a, stage IIB</p>
<p>T1a, stage I</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>SBDS</em>
</p>
<p>c.258+2T&gt;C</p>
<p>rs113993993</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">P (PVS1, PS3, PP5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.0039</p>
<p>FIN 0.0094</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.014</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Shwachman‐Diamond syndrome, definitive</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Shwachman‐Diamond syndrome 1 (OMIM 260400, risk of acute myeloid leukemia)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">UMG10‐74</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM (47y), breast ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">T2a, stage IIA</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>TRIM37</em>
</p>
<p>c.493‐2A&gt;G</p>
<p>rs186251998</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">P (PVS1, PM2, PP5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.00080</p>
<p>FIN 0.0085</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0047</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Mulibrey nanism, definitive</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Mulibrey nanism (OMIM 253250, risk for ovarian and Wilms tumor)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">UMG10‐49</td>
<td align="center" valign="top" rowspan="1" colspan="1">UM (60y), rectum ca</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">T1a, stage I</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<em>WRN</em>
</p>
<p>c.2665C&gt;T</p>
<p>Arg889*</p>
<p>rs774765029</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">P (PVS1, PM2, PP5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>All 0.000024</p>
<p>FIN 0</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0047</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Werner syndrome, definitive</td>
<td align="center" valign="top" rowspan="1" colspan="1">AR Werner syndrome (OMIM 277700, risk of thyroid cancer, melanoma on the skin, soft tissue sarcoma, osteosarcoma)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pcmr70041-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="pcmr70041-note-0014"><p>
<em>Note:</em> Patients identified with more than one pathogenic variant are highlighted in bold. Variants were classified using the American College of Medical Genetics and Genomics guidelines (Richards et al. <a href="#pcmr70041-bib-0053" class="usa-link" aria-describedby="pcmr70041-bib-0053">2015</a>).</p></div>
<div class="fn" id="pcmr70041-note-0015"><p>Abbreviations: ACMG , The American College of Medical Genetics and Genomics; BCC , basal cell carcinoma; BP1 , Missense variant in a gene for which primarily truncating variants are known to cause disease; BP4 , Multiple lines of computational evidence suggest no impact; CLL , chronic lymphocytic leukemia; ES , exome sequencing; F , female; FIN , Finnish population; FUM , familial uveal melanoma; LP , likely pathogenic; M , male; P , pathogenic; PM1 , Located in a mutational hot spot and/or critical and well‐established functional domain without benign variation; PM2 , Absent or very rare from race‐matched controls gnomAD; PM5 , Novel missense change at an amino acid residue where a different missense change determined to be pathogenic has been seen before; PP5 , Reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation; PS3 , Well‐established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product; PVS1 , Null variant in a gene where loss of function is a known mechanism of disease; RCC , renal cell carcinoma; TAS , targeted amplicon sequencing; TNM , tumor, node, metastasis; UM , uveal melanoma; y , years upon diagnosis.</p></div>
</div></section><p>Three females carried the common <em>CHEK2</em> variant c.470T&gt;C; p.(Ile157Thr), along with an additional variant in <em>SDHB</em>, <em>FANCM</em>, or <em>HOXB13</em> (Table <a href="#pcmr70041-tbl-0002" class="usa-link">2</a>). Pathogenic <em>CHEK2</em> variants cause a dominant risk of breast, prostate, colorectal, and possibly other cancers (Kilpivaara et al. <a href="#pcmr70041-bib-0032" class="usa-link" aria-describedby="pcmr70041-bib-0032">2004</a>; Stolarova et al. <a href="#pcmr70041-bib-0062" class="usa-link" aria-describedby="pcmr70041-bib-0062"><sup>2020</sup></a>; Breast Cancer Association Consortium et al. <a href="#pcmr70041-bib-0007" class="usa-link" aria-describedby="pcmr70041-bib-0007"><sup>2021</sup></a>). The <em>CHEK2</em> c.470T&gt;C variant is a low‐risk cancer variant (Hanson et al. <a href="#pcmr70041-bib-0021" class="usa-link" aria-describedby="pcmr70041-bib-0021">2023</a>). It is classified as pathogenic (5), likely pathogenic (13), pathogenic with low penetrance (1), established risk allele (1), and of uncertain significance (9) in the ClinVar database. The first patient, diagnosed with a T3a, stage IIB UM at 22, also carried a pathogenic <em>SDHB</em> c.716_719delCTCT; p.(Ser239Tyrfs*7) variant, associated with paragangliomas, pheochromocytomas, gastrointestinal stromal tumors, and RCC (Vanharanta et al. <a href="#pcmr70041-bib-0066" class="usa-link" aria-describedby="pcmr70041-bib-0066">2004</a>; MacFarlane et al. <a href="#pcmr70041-bib-0038" class="usa-link" aria-describedby="pcmr70041-bib-0038"><sup>2020</sup></a>). The second, diagnosed with a T2a, stage IIA UM at 41, was additionally heterozygous for a pathogenic <em>FANCM</em> c.5101C&gt;T; p.(Gln1701*) variant associated with a 2‐fold breast cancer risk (Kiiski et al. <a href="#pcmr70041-bib-0030" class="usa-link" aria-describedby="pcmr70041-bib-0030">2014</a>; Foulkes <a href="#pcmr70041-bib-0016" class="usa-link" aria-describedby="pcmr70041-bib-0016"><sup>2021</sup></a>). The third, diagnosed with a pulmonary carcinoid tumor and a T3a, stage IIB UM at the ages of 64 and 66, respectively, carried the <em>HOXB13</em> c.251G&gt;A; p.(Gly84Glu) variant linked to low risk of prostate and possibly other cancers in males (Wei et al. <a href="#pcmr70041-bib-0071" class="usa-link" aria-describedby="pcmr70041-bib-0071">2020</a>). The variant is classified in ClinVar as pathogenic (11), likely pathogenic (7), and of uncertain significance (1) (Table <a href="#pcmr70041-tbl-0002" class="usa-link">2</a>, Figure <a href="#pcmr70041-supitem-0002" class="usa-link">S2</a>).</p>
<p>A male, with a T3a, stage IIB, UM at age 45 years, was heterozygous for the dominantly inherited likely pathogenic <em>SDHA</em> c.1210C&gt;T; p.(Pro404Ser) variant and the <em>BLM</em> c.2824‐2A&gt;T variant, associated with recessive Bloom syndrome (Tables <a href="#pcmr70041-tbl-0002" class="usa-link">2</a> and <a href="#pcmr70041-tbl-0003" class="usa-link">3</a>, Figure <a href="#pcmr70041-supitem-0002" class="usa-link">S2</a>). He had previously been reported to have the <em>BLM</em> variant (Repo et al. <a href="#pcmr70041-bib-0052" class="usa-link" aria-describedby="pcmr70041-bib-0052">2024</a>), while the <em>SDHA</em> variant was discovered after exome sequencing. Pathogenic <em>SDHA</em> variants predispose to paragangliomas, pheochromocytomas, and RCC, albeit with lower penetrance than <em>SDHB</em> variants (MacFarlane et al. <a href="#pcmr70041-bib-0038" class="usa-link" aria-describedby="pcmr70041-bib-0038"><sup>2020</sup></a>; Maniam et al. <a href="#pcmr70041-bib-0039" class="usa-link" aria-describedby="pcmr70041-bib-0039"><sup>2018</sup></a>). Patients with Bloom syndrome, characterized by short stature, narrow face, and red skin rash, are predisposed to various cancers at an early age. In contrast, the cancer risk for heterozygous carriers is pending confirmation (Cunniff et al. <a href="#pcmr70041-bib-0010" class="usa-link" aria-describedby="pcmr70041-bib-0010">2017</a>; Bononi et al. <a href="#pcmr70041-bib-0006" class="usa-link" aria-describedby="pcmr70041-bib-0006"><sup>2020</sup></a>).</p>
<p>Another male, diagnosed with RCC at 56 and a T3a, stage IIB, UM at 57, was heterozygous for pathogenic variants c.1390+2del in <em>RECQL4</em> and c.258+2 T&gt;C in <em>SBDS</em> (Table <a href="#pcmr70041-tbl-0003" class="usa-link">3</a>, Figure <a href="#pcmr70041-supitem-0002" class="usa-link">S2</a>). The <em>RECQL4</em> variant is associated with recessive multisystem RAPADILINO, Rothmund‐Thomson, and Baller‐Gerold syndromes with a risk of osteosarcoma and lymphoma (Siitonen et al. <a href="#pcmr70041-bib-0058" class="usa-link" aria-describedby="pcmr70041-bib-0058">2009</a>). The <em>SBDS</em> variant is common in recessive Schwachman‐Diamond syndrome with a risk of myelodysplastic syndrome and acute myeloid leukemia (Nelson and Myers <a href="#pcmr70041-bib-0044" class="usa-link" aria-describedby="pcmr70041-bib-0044">1993</a>).</p>
<p>Finally, a male patient was heterozygous for three pathogenic variants: c.1100delC; p.(Thr367Metfs*15) in <em>CHEK2</em>, c.687delT; p.(Ser229Argfs*6) in <em>RAD50</em>, and c.3019del; p.(Leu1007Cysfs*62) in <em>CTC1</em> (Tables <a href="#pcmr70041-tbl-0002" class="usa-link">2</a> and <a href="#pcmr70041-tbl-0003" class="usa-link">3</a>, Figure <a href="#pcmr70041-supitem-0002" class="usa-link">S2</a>). The patient had a bladder carcinoma at 52 years and a T2a, stage IIA, UM at 69 years. His brother had CM, two other first‐degree relatives had unspecified malignancies, and a maternal aunt had renal tumors. The pathogenic <em>CHEK2</em> variant carries a 2‐fold cancer risk (Kilpivaara et al. <a href="#pcmr70041-bib-0032" class="usa-link" aria-describedby="pcmr70041-bib-0032">2004</a>; Breast Cancer Association Consortium et al. <a href="#pcmr70041-bib-0007" class="usa-link" aria-describedby="pcmr70041-bib-0007"><sup>2021</sup></a>), while the pathogenic <em>RAD50</em> Finnish founder variant is a hypothesized low‐penetrance breast cancer susceptibility allele (Heikkinen et al. <a href="#pcmr70041-bib-0023" class="usa-link" aria-describedby="pcmr70041-bib-0023">2006</a>). Compound heterozygous <em>CTC1</em> variants cause cerebroretinal microangiopathy with calcifications and cysts (Polvi et al. <a href="#pcmr70041-bib-0047" class="usa-link" aria-describedby="pcmr70041-bib-0047">2012</a>; Anderson et al. <a href="#pcmr70041-bib-0004" class="usa-link" aria-describedby="pcmr70041-bib-0004"><sup>2012</sup></a>) and <em>CTC1</em> is included in Genomics England PanelApp's hematological malignancy genepanel (Shen et al. <a href="#pcmr70041-bib-0057" class="usa-link" aria-describedby="pcmr70041-bib-0057">2019</a>; Furutani and Shimamura <a href="#pcmr70041-bib-0017" class="usa-link" aria-describedby="pcmr70041-bib-0017"><sup>2017</sup></a>).</p>
<p>Four variants, <em>CHEK2</em> c.470T&gt;C; p.(Ile157Thr), <em>FANCM</em> c.5101C&gt;T; p.(Gln1701*), <em>HOXB13</em> c.251G&gt;A; p.(Gly84Glu), and <em>RAD50</em> c.687delT; p.(Ser229Argfs*6), enriched in the Finnish population (gnomAD MAF &gt; 0.001), were each identified as the only P/LP variant in five, two, two, and one patient, respectively. When including carriers of multiple variants, the odds ratios (OR) were all &gt; 1, being 1.53 (95% CI; 0.65–3.09, <em>p</em> = 0.26) for <em>CHEK2</em>, 1.76 (95% CI; 0.36–5.29, <em>p</em> = 0.25) for <em>FANCM</em>, 1.24 (95% CI; 0.15–4.6, <em>p</em> = 0.68) for <em>HOXB13</em>, and 2.11 (95% CI; 0.25–7.88, <em>p</em> = 0.25) for <em>RAD50</em>, respectively (Table <a href="#pcmr70041-supitem-0006" class="usa-link">S4</a>). Additionally, a pathogenic variant c.415_418dupGATG in <em>DDX41</em> was identified in a female with myotonic dystrophy, thyroid and renal cysts, and a T2a, stage IIA, UM at age 41 years. Myotonic dystrophy increases the risk of cancer (Emparanza et al. <a href="#pcmr70041-bib-0013" class="usa-link" aria-describedby="pcmr70041-bib-0013">2018</a>), and a risk of UM is speculated (Guneri Beser and Demirci <a href="#pcmr70041-bib-0018" class="usa-link" aria-describedby="pcmr70041-bib-0018"><sup>2024</sup></a>; Velazquez‐Martin et al. <a href="#pcmr70041-bib-0067" class="usa-link" aria-describedby="pcmr70041-bib-0067"><sup>2013</sup></a>; Dalvin et al. <a href="#pcmr70041-bib-0011" class="usa-link" aria-describedby="pcmr70041-bib-0011"><sup>2018</sup></a>). The patient had a family history of CM and breast cancer. The variant is associated with a low‐to‐moderate risk of myelo‐ and lymphoproliferative neoplasms (Bannon et al. <a href="#pcmr70041-bib-0005" class="usa-link" aria-describedby="pcmr70041-bib-0005">2020</a>). However, IGV inspection showed an allele frequency of 21%, suggesting a possible somatic origin of the variant (Table <a href="#pcmr70041-tbl-0002" class="usa-link">2</a>, Figure <a href="#pcmr70041-supitem-0002" class="usa-link">S2</a>).</p>
<p>To our knowledge, P/LP germline variants in <em>DDX41</em>, <em>HOXB13</em>, <em>RAD50</em>, <em>SDHA</em>, and <em>SDHB</em> in patients with UM are novel findings. Without tumor biopsies, a limitation of our study, the germline variants' role in UM tumorigenesis remains open. The <em>HOXB13</em> c.251G&gt;A, <em>RAD50</em> c.687delT, and <em>CHEK2</em> c.470 T&gt;C variants are linked to the prostate (Wei et al. <a href="#pcmr70041-bib-0071" class="usa-link" aria-describedby="pcmr70041-bib-0071">2020</a>), breast (Heikkinen et al. <a href="#pcmr70041-bib-0023" class="usa-link" aria-describedby="pcmr70041-bib-0023">2006</a>), or both (Hanson et al. <a href="#pcmr70041-bib-0021" class="usa-link" aria-describedby="pcmr70041-bib-0021">2023</a>) cancers, are relatively common in Finland and may appear in our cohort by chance. However, their co‐occurrence with another pathogenic variant is less likely, warranting further studies in larger UM cohorts. The OR of the variants observed in multiple individuals must be considered exploratory, given that they are not statistically significant as compared to the Finnish population in gnomAD (Table <a href="#pcmr70041-supitem-0006" class="usa-link">S4</a>), which reflects the small numbers of patients available from a rare cancer in a small population of 5.6 million. As we failed to resolve the genetic background of additional Finnish patients with FUM not linked to BAP1‐TPDS (Repo et al. <a href="#pcmr70041-bib-0051" class="usa-link" aria-describedby="pcmr70041-bib-0051">2019</a>; Turunen et al. <a href="#pcmr70041-bib-0065" class="usa-link" aria-describedby="pcmr70041-bib-0065"><sup>2016</sup></a>), mutated <em>BAP1</em> remains the main monogenic UM risk factor.</p>
<p>Our results replicate two previously reported UM‐associated germline discoveries. The other <em>CHEK2</em> variant, c.1100delC p.(Thr367Metfs*15), was identified in Ohio in a patient with UM, RCC, and basal cell carcinoma, as well as a family history of CM and breast cancer (Abdel‐Rahman et al. <a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002"><sup>2020</sup></a>). A likely pathogenic <em>FANCM</em> variant c.636dup; p.(Ile213Tyrfs*2) was found in a male UM patient from the Cancer Genome Atlas (TCGA) cohort (Huang et al. <a href="#pcmr70041-bib-0024" class="usa-link" aria-describedby="pcmr70041-bib-0024">2018</a>). Of note, the association of <em>FANCM</em> with dominant cancer risk remains unconfirmed (Kiiski et al. <a href="#pcmr70041-bib-0030" class="usa-link" aria-describedby="pcmr70041-bib-0030">2014</a>; Morales‐Pison et al. <a href="#pcmr70041-bib-0041" class="usa-link" aria-describedby="pcmr70041-bib-0041"><sup>2023</sup></a>; Kiiski et al. <a href="#pcmr70041-bib-0031" class="usa-link" aria-describedby="pcmr70041-bib-0031"><sup>2017</sup></a>; Figlioli et al. <a href="#pcmr70041-bib-0014" class="usa-link" aria-describedby="pcmr70041-bib-0014"><sup>2023</sup></a>).</p>
<p>No deleterious germline <em>MBD4</em> variants were identified in Finnish patients with UM, consistent with our previous study on an overlapping cohort (Figure <a href="#pcmr70041-supitem-0001" class="usa-link">S1</a>) (Repo et al. <a href="#pcmr70041-bib-0050" class="usa-link" aria-describedby="pcmr70041-bib-0050">2020</a>). We also identified no P/LP germline variants in <em>ATM</em>, <em>ATR</em>, <em>BRCA1</em>, <em>BRCA2</em>, <em>BRIP1</em>, <em>CDKN2A</em>, <em>CTNNA1</em>, <em>FANCD2</em>, <em>FLCN</em>, <em>MET</em>, <em>MITF</em>, <em>MLH1</em>, <em>MSH6</em>, <em>NBN</em>, <em>PALB2</em>, <em>POT1</em>, or <em>SMARCE1</em>, previously reported in patients with UM (Table <a href="#pcmr70041-tbl-0001" class="usa-link">1</a>) (Cruz et al. <a href="#pcmr70041-bib-0009" class="usa-link" aria-describedby="pcmr70041-bib-0009">2011</a>; Repo et al. <a href="#pcmr70041-bib-0052" class="usa-link" aria-describedby="pcmr70041-bib-0052"><sup>2024</sup></a>; Iscovich et al. <a href="#pcmr70041-bib-0025" class="usa-link" aria-describedby="pcmr70041-bib-0025"><sup>2002</sup></a>; Sinilnikova et al. <a href="#pcmr70041-bib-0060" class="usa-link" aria-describedby="pcmr70041-bib-0060"><sup>1999</sup></a>; Huang et al. <a href="#pcmr70041-bib-0024" class="usa-link" aria-describedby="pcmr70041-bib-0024"><sup>2018</sup></a>; Abdel‐Rahman et al. <a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002"><sup>2020</sup></a>; Hajkova et al. <a href="#pcmr70041-bib-0020" class="usa-link" aria-describedby="pcmr70041-bib-0020"><sup>2018</sup></a>; Lobo et al. <a href="#pcmr70041-bib-0037" class="usa-link" aria-describedby="pcmr70041-bib-0037"><sup>2017</sup></a>; Hearle et al. <a href="#pcmr70041-bib-0022" class="usa-link" aria-describedby="pcmr70041-bib-0022"><sup>2003</sup></a>; Kannengiesser et al. <a href="#pcmr70041-bib-0028" class="usa-link" aria-describedby="pcmr70041-bib-0028"><sup>2003</sup></a>; Fontcuberta et al. <a href="#pcmr70041-bib-0015" class="usa-link" aria-describedby="pcmr70041-bib-0015"><sup>2011</sup></a>; Nathan et al. <a href="#pcmr70041-bib-0043" class="usa-link" aria-describedby="pcmr70041-bib-0043"><sup>2021</sup></a>; Johansson et al. <a href="#pcmr70041-bib-0026" class="usa-link" aria-describedby="pcmr70041-bib-0026"><sup>2025</sup></a>).</p>
<p>Genetic testing is increasingly performed using gene panels and exome sequencing, leading to a growing number of patients identified with multiple cancer risk variants. Such patients, now thought to have MINAS, can exhibit overlapping or more severe or atypical cancer phenotypes due to additive or synergistic effects of variants (Whitworth et al. <a href="#pcmr70041-bib-0072" class="usa-link" aria-describedby="pcmr70041-bib-0072">2016</a>; McGuigan et al. <a href="#pcmr70041-bib-0040" class="usa-link" aria-describedby="pcmr70041-bib-0040"><sup>2022</sup></a>). However, the co‐occurrence of multiple cancer‐associated variants is rare; in Finland, the estimated frequency of double heterozygotes in dominant cancer genes without phenotypic selection is 0.25% (Laitman et al. <a href="#pcmr70041-bib-0035" class="usa-link" aria-describedby="pcmr70041-bib-0035">2024</a>). Nevertheless, six Finnish patients with UM (6% of all patients; 21% of carriers of P/LP variants) had co‐occurring variants, with a 3.8% frequency when considered only dominant cancer genes (Table <a href="#pcmr70041-tbl-0002" class="usa-link">2</a>). Though <em>CHEK2</em> variants have been reported in MINAS patients (McGuigan et al. <a href="#pcmr70041-bib-0040" class="usa-link" aria-describedby="pcmr70041-bib-0040"><sup>2022</sup></a>; Laitman et al. <a href="#pcmr70041-bib-0035" class="usa-link" aria-describedby="pcmr70041-bib-0035"><sup>2024</sup></a>), the c.470 T&gt;C may not qualify as MINAS‐causing due to its low associated risk. Comparing MINAS frequencies across studies poses challenges due to the lack of uniform reporting guidelines.</p>
<p>The median age at UM diagnosis for multilocus variant carriers was 51 years (range, 22–69), compared to 60 in the entire cohort and 65 (range, 15–90) in our overlapping larger consecutive series (Repo et al. <a href="#pcmr70041-bib-0051" class="usa-link" aria-describedby="pcmr70041-bib-0051">2019</a>). This aligns with BAP1‐TPDS, where the median UM diagnosis age is 53–54 years, compared to the general median of 62–65 years (Repo et al. <a href="#pcmr70041-bib-0051" class="usa-link" aria-describedby="pcmr70041-bib-0051">2019</a>; Pilarski et al. <a href="#pcmr70041-bib-0046" class="usa-link" aria-describedby="pcmr70041-bib-0046"><sup>2016</sup></a>; Walpole et al. <a href="#pcmr70041-bib-0069" class="usa-link" aria-describedby="pcmr70041-bib-0069"><sup>2018</sup></a>), and two previously reported patients with UM and multilocus variants (Johansson et al. <a href="#pcmr70041-bib-0026" class="usa-link" aria-describedby="pcmr70041-bib-0026">2025</a>; Abdel‐Rahman et al. <a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002"><sup>2020</sup></a>). A younger‐than‐average patient with UM (51 years), with a family history of pancreatic, breast, and colon carcinoma, was identified in Ohio as a carrier of <em>CHEK2</em> c.470T&gt;C; p.(Ile157Thr)—also found in three of our patients—and a pathogenic <em>PALB2</em> c.49‐1G&gt;A (Abdel‐Rahman et al. <a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002"><sup>2020</sup></a>). Another patient from the same study, diagnosed with UM at an even younger age of 46, carried an LP <em>SMARCE1</em> c.373G&gt;T; p.(Glu123*) variant and an LP <em>MHS6</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000179.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000179.3</a>) c.3495C&gt;G p.(Cys1165Trp) missense variant (Table <a href="#pcmr70041-tbl-0001" class="usa-link">1</a>), originally classified (Abdel‐Rahman et al. <a href="#pcmr70041-bib-0002" class="usa-link" aria-describedby="pcmr70041-bib-0002"><sup>2020</sup></a>) as a VUS [note that original publication nomenclature c.2589C&gt;G; p.(Cys863Trp) falls in alternative transcripts]. The patient developed endometrial cancer at 51 and had a family history of UM and non‐melanoma skin cancer. Nuclear SMARCE1 staining was detected in both index tumors, whereas MSH6 staining was reduced or absent. Third, a male patient from Australia carried a pathogenic <em>BRIP1</em> variant c.2392C&gt;T p.(Arg798*) and another pathogenic variant c.3226C&gt;T p.(Arg1076Cys) in <em>MSH6</em> (Johansson et al. <a href="#pcmr70041-bib-0026" class="usa-link" aria-describedby="pcmr70041-bib-0026">2025</a>). He was diagnosed with UM at 39 and cutaneous melanoma at 47. He also reported two first‐ or second‐degree relatives affected by cutaneous melanoma, mucosal melanoma, astrocytoma, and thyroid cancer, though further details were not specified. Additionally, the patient was heterozygous for a pathogenic recessive <em>TYR</em> variant c.1118C&gt;A p.(Thr373Lys) associated with oculocutaneous albinism, but speculated to contribute also to cutaneous melanoma risk (Nathan et al. <a href="#pcmr70041-bib-0042" class="usa-link" aria-describedby="pcmr70041-bib-0042">2019</a>).</p>
<p>Beyond the lack of tumor biopsies, our study has additional limitations. First, we aimed to identify novel UM predisposition genes and excluded patients with pathogenic germline <em>BAP1</em> variants, preventing the assessment of multilocus variants in these individuals. Second, short‐read sequencing and filtering criteria might have missed pathogenic variants such as large copy‐number changes. Additionally, variant classifications may change with new data. Lastly, gender, wide age range, and early mortality of patients with high‐risk UM can introduce bias in enrollment and follow‐up for non‐ocular cancers.</p>
<p>In conclusion, the 6% frequency of multilocus variant carriers in our selected cohort was high, comparable to the 3.2% frequency of BAP1‐TPDS in Finnish patients with UM diagnosed before the age of 50 years (Repo et al. <a href="#pcmr70041-bib-0051" class="usa-link" aria-describedby="pcmr70041-bib-0051">2019</a>). Therefore, we propose genetic testing beyond <em>BAP1</em> for UM patients diagnosed at 45 years of age or younger, those with additional non‐ocular cancers, FUM, or a strong family history of cancer. The emerging concept of MINAS informs new research directions into the genetic basis of UM and may have implications for individual patient care. While the synergistic effect of multiple variants remains speculative, surveillance strategies and risk‐reducing measures should be guided by established recommendations for each individual finding, considering the spectrum of malignancies associated with each pathogenic variant. Nonetheless, identifying a pathogenic variant, regardless of multiplicity, can be clinically significant and warrants appropriate management. Further genetic entities may remain undiscovered, explaining still unresolved FUM.</p></section><section id="pcmr70041-sec-0004"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>
<strong>Pauliina E. Repo:</strong> investigation, visualization, formal analysis, writing – original draft. <strong>Eveliina Jakkula:</strong> validation, writing – review and editing. <strong>Juho Hiltunen</strong> and <strong>Heidi Putkuri:</strong> software, formal analysis. <strong>Aleksandra Staskiewicz‐Tuikkanen</strong>, <strong>Martin Täll</strong>, <strong>Virpi Raivio</strong>, and <strong>Rana'a T. Al‐Jamal:</strong> resources. <strong>Reetta‐Stiina Järvinen:</strong> resources, investigation, writing – original draft. <strong>Tero T. Kivelä:</strong> data curation, validation, supervision, funding acquisition, writing – review and editing. <strong>Joni A. Turunen:</strong> conceptualization, supervision, project administration, funding acquisition, Validation, writing – review and editing.</p></section><section id="pcmr70041-sec-0006"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>All participants gave written informed consent. The project was approved by the institutional review board of the Hospital Region of Helsinki and Uusimaa on June 11, 2012, and it followed the tenets of the Declaration of Helsinki.</p></section><section id="pcmr70041-sec-0005"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>Joni A. Turunen received lecture fees from Thea Finland and Santen Finland, and served as a consultant for Maculaser Oy. Tero T. Kivelä received lecture fees from Santen Finland. All are unrelated to this work. All other authors declare no competing financial or non‐financial interests.</p></section><section id="sec5"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pcmr70041-supitem-0001"><div class="caption p"><p>
<strong>Figure S1:</strong> Overlapping study cohorts Five overlapping cohorts of Finnish patients with uveal melanoma (UM) have been used in germline variant analyses. The initial <em>BAP1</em> variant analysis of 148 patients (Turunen et al. <a href="#pcmr70041-bib-0065" class="usa-link" aria-describedby="pcmr70041-bib-0065">2016</a>) was included in the 433 patients published later (Repo et al. <a href="#pcmr70041-bib-0051" class="usa-link" aria-describedby="pcmr70041-bib-0051">2019</a>) and is not specified further. References to the original publications are provided below.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334930/bin/PCMR-38-0-s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">PCMR-38-0-s002.pdf</a><sup> (1.4MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="pcmr70041-supitem-0002"><div class="caption p"><p>
<strong>Figure S2:</strong> Representative Integrative Genomics Viewer (IGV) captures exome sequencing reads with identified pathogenic (P) and likely pathogenic (LP) germline variants. (A–F) depicts multilocus variant carriers and (G–Q) single variant carriers when occurring in genes associated with dominant cancer risk. Recessive alleles are depicted when co‐occurring in the patient with another P/LP variant. Variant allele frequency (VAF) was calculated from the total sequencing depth (DP) observed in IGV and can differ from the VAF of the annotated Variant Call Format (VCF) file because of read filtering (quality, duplicate).</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334930/bin/PCMR-38-0-s003.pdf" data-ga-action="click_feat_suppl" class="usa-link">PCMR-38-0-s003.pdf</a><sup> (5.4MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="pcmr70041-supitem-0003"><div class="caption p"><p>
<strong>Table S1:</strong> Genes analyzed Tumor‐associated phenotypes and cancer candidate genes were obtained from PanelApp, the Cancer Gene Census (CGC) database, and literature. Note that PanelApp phenotypes may present borderline evidence (amber) for associations with specific phenotypes and associated germline/somatic status was not distinguished. For candidate cancer genes outside the databases, a publication DOI is provided.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334930/bin/PCMR-38-0-s004.pdf" data-ga-action="click_feat_suppl" class="usa-link">PCMR-38-0-s004.pdf</a><sup> (42.2KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="pcmr70041-supitem-0004"><div class="caption p"><p>
<strong>Table S2:</strong> Characteristics of 106 eligible Finnish patients with primary uveal melanoma and higher‐than‐average cancer risk at the time of diagnosis, and their disease outcome.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334930/bin/PCMR-38-0-s005.docx" data-ga-action="click_feat_suppl" class="usa-link">PCMR-38-0-s005.docx</a><sup> (17.3KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pcmr70041-supitem-0005"><div class="caption p"><p>
<strong>Table S3:</strong> Variants of unknown significance (VUS) identified among Finnish patients with primary uveal melanoma and higher‐than‐average cancer risk, matching the filtering criteria. Patients identified with more than one VUS are highlighted in <strong>bold</strong>.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334930/bin/PCMR-38-0-s006.pdf" data-ga-action="click_feat_suppl" class="usa-link">PCMR-38-0-s006.pdf</a><sup> (11KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="pcmr70041-supitem-0006"><div class="caption p"><p>
<strong>Table S4:</strong> Odds ratios (OR) for Frequent Variants Pathogenic and likely pathogenic variants observed in multiple patients were tested for enrichment in Finnish patients with uveal melanoma (UM_FIN) compared to Finnish population controls from gnomAD v2.1.1 (gnomAD_FIN).</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334930/bin/PCMR-38-0-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">PCMR-38-0-s001.pdf</a><sup> (269.8KB, pdf) </sup>
</div></div></section></section><section id="pcmr70041-sec-0009" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>NGS library preparation, sequencing, and FIMM Variant Calling Pipeline analysis were performed by the Institute for Molecular Medicine Finland FIMM Technology Centre, University of Helsinki. Open access publishing facilitated by Helsingin yliopisto, as part of the Wiley ‐ FinELib agreement.</p></section><section id="notes1"><p>


Repo, P. E.
, Jakkula E., Hiltunen J., et al. 2025. “Germline Cancer Susceptibility Variants in Patients With Uveal Melanoma.” Pigment Cell &amp; Melanoma Research
38, no. 5: e70041. 10.1111/pcmr.70041.
</p>
<section id="pcmr70041-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="pcmr70041-note-0001"><p>
<strong>Funding:</strong> This work was funded by the Helsinki University Hospital Research Fund [Grant TYH2023312 to Tero T. Kivelä and TYH2023338 to Joni A. Turunen]; The Eye and Tissue Bank Foundation, Helsinki, Finland; Mary and Georg C. Ehrnrooth Foundation, Helsinki, Finland; Evald and Hilda Nissi Foundation, Vaasa, Finland; The Eye Foundation, Helsinki, Finland; and The Cancer Foundation, Helsinki, Finland. The funder played no role in the study design, data collection, analysis, interpretation of data, or the writing of this manuscript.</p></div>
<div class="fn p" id="pcmr70041-note-0002"><p>Tero T. Kivelä and Joni A. Turunen contributed equally as co‐last authors.</p></div>
</div></section></section><section id="pcmr70041-sec-0008"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The data are available from the corresponding author upon reasonable request.</p></section><section id="pcmr70041-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="pcmr70041-bibl-0001_sec2"><ol class="ref-list font-sm">
<li id="pcmr70041-bib-0001">
<cite>

Abdel‐Rahman, M. H.
, Pilarski R., Ezzat S., Sexton J., and Davidorf F. H.. 2010. “Cancer Family History Characterization in an Unselected Cohort of 121 Patients With Uveal Melanoma.” Familial Cancer
9, no. 3: 431–438. 10.1007/s10689-010-9328-7.
</cite> [<a href="https://doi.org/10.1007/s10689-010-9328-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20157784/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Familial%20Cancer&amp;title=Cancer%20Family%20History%20Characterization%20in%20an%20Unselected%20Cohort%20of%20121%20Patients%20With%20Uveal%20Melanoma&amp;author=M.%20H.%20Abdel%E2%80%90Rahman&amp;author=R.%20Pilarski&amp;author=S.%20Ezzat&amp;author=J.%20Sexton&amp;author=F.%20H.%20Davidorf&amp;volume=9&amp;issue=3&amp;publication_year=2010&amp;pages=431-438&amp;pmid=20157784&amp;doi=10.1007/s10689-010-9328-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0002">
<cite>

Abdel‐Rahman, M. H.
, Sample K. M., Pilarski R., Walsh T., Grosel T., and Kinnamon D.. 2020. “Whole Exome Sequencing Identifies Candidate Genes Associated With Hereditary Predisposition to Uveal Melanoma.” Ophthalmology
127, no. 5: 668–678. 10.1016/j.ophtha.2019.11.009.
</cite> [<a href="https://doi.org/10.1016/j.ophtha.2019.11.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7183432/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32081490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmology&amp;title=Whole%20Exome%20Sequencing%20Identifies%20Candidate%20Genes%20Associated%20With%20Hereditary%20Predisposition%20to%20Uveal%20Melanoma&amp;author=M.%20H.%20Abdel%E2%80%90Rahman&amp;author=K.%20M.%20Sample&amp;author=R.%20Pilarski&amp;author=T.%20Walsh&amp;author=T.%20Grosel&amp;volume=127&amp;issue=5&amp;publication_year=2020&amp;pages=668-678&amp;pmid=32081490&amp;doi=10.1016/j.ophtha.2019.11.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0003">
<cite>

Albright, B. B.
, Wignall E., Bentley R. C., Havrilesky L. J., Previs R. A., and Strickland K. C.. 2023. “BAP1 Tumor Predisposition Syndrome Presenting as a Recurrent Ovarian Sex Cord‐Stromal Tumor.” International Journal of Gynecological Pathology
42, no. 1: 83–88. 10.1097/PGP.0000000000000855.
</cite> [<a href="https://doi.org/10.1097/PGP.0000000000000855" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10089687/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35348477/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Gynecological%20Pathology&amp;title=BAP1%20Tumor%20Predisposition%20Syndrome%20Presenting%20as%20a%20Recurrent%20Ovarian%20Sex%20Cord%E2%80%90Stromal%20Tumor&amp;author=B.%20B.%20Albright&amp;author=E.%20Wignall&amp;author=R.%20C.%20Bentley&amp;author=L.%20J.%20Havrilesky&amp;author=R.%20A.%20Previs&amp;volume=42&amp;issue=1&amp;publication_year=2023&amp;pages=83-88&amp;pmid=35348477&amp;doi=10.1097/PGP.0000000000000855&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0004">
<cite>

Anderson, B. H.
, Kasher P. R., Mayer J., et al. 2012. “Mutations in CTC1, Encoding Conserved Telomere Maintenance Component 1, Cause Coats Plus.” Nature Genetics
44, no. 3: 338–342. 10.1038/ng.1084.
</cite> [<a href="https://doi.org/10.1038/ng.1084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22267198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Genetics&amp;title=Mutations%20in%20CTC1,%20Encoding%20Conserved%20Telomere%20Maintenance%20Component%201,%20Cause%20Coats%20Plus&amp;author=B.%20H.%20Anderson&amp;author=P.%20R.%20Kasher&amp;author=J.%20Mayer&amp;volume=44&amp;issue=3&amp;publication_year=2012&amp;pages=338-342&amp;pmid=22267198&amp;doi=10.1038/ng.1084&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0005">
<cite>

Bannon, S. A.
, Routbort M. J., Montalban‐Bravo G., et al. 2020. “Next‐Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations.” Frontiers in Oncology
10: 582213. 10.3389/fonc.2020.582213.
</cite> [<a href="https://doi.org/10.3389/fonc.2020.582213" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7878971/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33585199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Oncology&amp;title=Next%E2%80%90Generation%20Sequencing%20of%20DDX41%20in%20Myeloid%20Neoplasms%20Leads%20to%20Increased%20Detection%20of%20Germline%20Alterations&amp;author=S.%20A.%20Bannon&amp;author=M.%20J.%20Routbort&amp;author=G.%20Montalban%E2%80%90Bravo&amp;volume=10&amp;publication_year=2020&amp;pages=582213&amp;pmid=33585199&amp;doi=10.3389/fonc.2020.582213&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0006">
<cite>

Bononi, A.
, Goto K., Ak G., et al. 2020. “Heterozygous Germline <em>BLM</em> Mutations Increase Susceptibility to Asbestos and Mesothelioma.” Proceedings of the National Academy of Sciences of the United States of America
117, no. 52: 33466–33473. 10.1073/pnas.2019652117.
</cite> [<a href="https://doi.org/10.1073/pnas.2019652117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7776606/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33318203/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20of%20the%20United%20States%20of%20America&amp;title=Heterozygous%20Germline%20BLM%20Mutations%20Increase%20Susceptibility%20to%20Asbestos%20and%20Mesothelioma&amp;author=A.%20Bononi&amp;author=K.%20Goto&amp;author=G.%20Ak&amp;volume=117&amp;issue=52&amp;publication_year=2020&amp;pages=33466-33473&amp;pmid=33318203&amp;doi=10.1073/pnas.2019652117&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0007">
<cite>
Breast Cancer Association Consortium
, 
Dorling, L.
, Carvalho S., et al. 2021. “Breast Cancer Risk Genes ‐ Association Analysis in More Than 113,000 Women.” New England Journal of Medicine
384, no. 5: 428–439. 10.1056/NEJMoa1913948.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1913948" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7611105/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33471991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Breast%20Cancer%20Risk%20Genes%20%E2%80%90%20Association%20Analysis%20in%20More%20Than%20113,000%20Women&amp;author=L.%20Dorling&amp;author=S.%20Carvalho&amp;volume=384&amp;issue=5&amp;publication_year=2021&amp;pages=428-439&amp;pmid=33471991&amp;doi=10.1056/NEJMoa1913948&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0008">
<cite>

Carbone, M.
, Pass H. I., Ak G., et al. 2022. “Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.” Journal of Thoracic Oncology
17, no. 7: 873–889. 10.1016/j.jtho.2022.03.014.
</cite> [<a href="https://doi.org/10.1016/j.jtho.2022.03.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9233126/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35462085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Thoracic%20Oncology&amp;title=Medical%20and%20Surgical%20Care%20of%20Patients%20With%20Mesothelioma%20and%20Their%20Relatives%20Carrying%20Germline%20BAP1%20Mutations&amp;author=M.%20Carbone&amp;author=H.%20I.%20Pass&amp;author=G.%20Ak&amp;volume=17&amp;issue=7&amp;publication_year=2022&amp;pages=873-889&amp;pmid=35462085&amp;doi=10.1016/j.jtho.2022.03.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0009">
<cite>

Cruz, C.
, Teule A., Caminal J. M., Blanco I., and Piulats J. M.. 2011. “Uveal Melanoma and <em>BRCA1/BRCA2</em> Genes: A Relationship That Needs Further Investigation.” Journal of Clinical Oncology
29, no. 34: e827–e829. 10.1200/JCO.2011.37.8828.
</cite> [<a href="https://doi.org/10.1200/JCO.2011.37.8828" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22025144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Oncology&amp;title=Uveal%20Melanoma%20and%20BRCA1/BRCA2%20Genes:%20A%20Relationship%20That%20Needs%20Further%20Investigation&amp;author=C.%20Cruz&amp;author=A.%20Teule&amp;author=J.%20M.%20Caminal&amp;author=I.%20Blanco&amp;author=J.%20M.%20Piulats&amp;volume=29&amp;issue=34&amp;publication_year=2011&amp;pages=e827-e829&amp;pmid=22025144&amp;doi=10.1200/JCO.2011.37.8828&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0010">
<cite>

Cunniff, C.
, Bassetti J. A., and Ellis N. A.. 2017. “Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition.” Molecular Syndromology
8, no. 1: 4–23. 10.1159/000452082.
</cite> [<a href="https://doi.org/10.1159/000452082" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5260600/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28232778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Syndromology&amp;title=Bloom's%20Syndrome:%20Clinical%20Spectrum,%20Molecular%20Pathogenesis,%20and%20Cancer%20Predisposition&amp;author=C.%20Cunniff&amp;author=J.%20A.%20Bassetti&amp;author=N.%20A.%20Ellis&amp;volume=8&amp;issue=1&amp;publication_year=2017&amp;pages=4-23&amp;pmid=28232778&amp;doi=10.1159/000452082&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0011">
<cite>

Dalvin, L. A.
, Shields C. L., Pulido J. S., Sioufi K., Cohen V., and Shields J. A.. 2018. “Uveal Melanoma Associated With Myotonic Dystrophy: A Report of 6 Cases.” JAMA Ophthalmology
136, no. 5: 543–547. 10.1001/jamaophthalmol.2018.0554.
</cite> [<a href="https://doi.org/10.1001/jamaophthalmol.2018.0554" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5876914/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29596556/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Ophthalmology&amp;title=Uveal%20Melanoma%20Associated%20With%20Myotonic%20Dystrophy:%20A%20Report%20of%206%20Cases&amp;author=L.%20A.%20Dalvin&amp;author=C.%20L.%20Shields&amp;author=J.%20S.%20Pulido&amp;author=K.%20Sioufi&amp;author=V.%20Cohen&amp;volume=136&amp;issue=5&amp;publication_year=2018&amp;pages=543-547&amp;pmid=29596556&amp;doi=10.1001/jamaophthalmol.2018.0554&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0012">
<cite>

Derrien, A. C.
, Rodrigues M., Eeckhoutte A., et al. 2021. “Germline <em>MBD4</em> Mutations and Predisposition to Uveal Melanoma.” Journal of the National Cancer Institute
113, no. 1: 80–87. 10.1093/jnci/djaa047.
</cite> [<a href="https://doi.org/10.1093/jnci/djaa047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7781447/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32239153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20National%20Cancer%20Institute&amp;title=Germline%20MBD4%20Mutations%20and%20Predisposition%20to%20Uveal%20Melanoma&amp;author=A.%20C.%20Derrien&amp;author=M.%20Rodrigues&amp;author=A.%20Eeckhoutte&amp;volume=113&amp;issue=1&amp;publication_year=2021&amp;pages=80-87&amp;pmid=32239153&amp;doi=10.1093/jnci/djaa047&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0013">
<cite>

Emparanza, J. I.
, Lopez de Munain A., Greene M. H., Matheu A., Fernandez‐Torron R., and Gadalla S. M.. 2018. “Cancer Phenotype in Myotonic Dystrophy Patients: Results From a Meta‐Analysis.” Muscle &amp; Nerve
58, no. 4: 517–522. 10.1002/mus.26194.
</cite> [<a href="https://doi.org/10.1002/mus.26194" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6173974/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30028904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Muscle%20&amp;%20Nerve&amp;title=Cancer%20Phenotype%20in%20Myotonic%20Dystrophy%20Patients:%20Results%20From%20a%20Meta%E2%80%90Analysis&amp;author=J.%20I.%20Emparanza&amp;author=A.%20Lopez%20de%20Munain&amp;author=M.%20H.%20Greene&amp;author=A.%20Matheu&amp;author=R.%20Fernandez%E2%80%90Torron&amp;volume=58&amp;issue=4&amp;publication_year=2018&amp;pages=517-522&amp;pmid=30028904&amp;doi=10.1002/mus.26194&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0014">
<cite>

Figlioli, G.
, Billaud A., Ahearn T. U., et al. 2023. “FANCM Missense Variants and Breast Cancer Risk: A Case‐Control Association Study of 75,156 European Women.” European Journal of Human Genetics
31, no. 5: 578–587. 10.1038/s41431-022-01257-w.
</cite> [<a href="https://doi.org/10.1038/s41431-022-01257-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10172381/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36707629/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Human%20Genetics&amp;title=FANCM%20Missense%20Variants%20and%20Breast%20Cancer%20Risk:%20A%20Case%E2%80%90Control%20Association%20Study%20of%2075,156%20European%20Women&amp;author=G.%20Figlioli&amp;author=A.%20Billaud&amp;author=T.%20U.%20Ahearn&amp;volume=31&amp;issue=5&amp;publication_year=2023&amp;pages=578-587&amp;pmid=36707629&amp;doi=10.1038/s41431-022-01257-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0015">
<cite>

Fontcuberta, I. C.
, Salomao D. R., Quiram P. A., and Pulido J. S.. 2011. “Choroidal Melanoma and Lid Fibrofoliculomas in Birt‐Hogg‐Dube Syndrome.” Ophthalmic Genetics
32, no. 3: 143–146. 10.3109/13816810.2010.544367.
</cite> [<a href="https://doi.org/10.3109/13816810.2010.544367" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21401403/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmic%20Genetics&amp;title=Choroidal%20Melanoma%20and%20Lid%20Fibrofoliculomas%20in%20Birt%E2%80%90Hogg%E2%80%90Dube%20Syndrome&amp;author=I.%20C.%20Fontcuberta&amp;author=D.%20R.%20Salomao&amp;author=P.%20A.%20Quiram&amp;author=J.%20S.%20Pulido&amp;volume=32&amp;issue=3&amp;publication_year=2011&amp;pages=143-146&amp;pmid=21401403&amp;doi=10.3109/13816810.2010.544367&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0016">
<cite>

Foulkes, W. D.

2021. “The Ten Genes for Breast (And Ovarian) Cancer Susceptibility.” Nature Reviews. Clinical Oncology
18, no. 5: 259–260. 10.1038/s41571-021-00491-3.</cite> [<a href="https://doi.org/10.1038/s41571-021-00491-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33692540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Clinical%20Oncology&amp;title=The%20Ten%20Genes%20for%20Breast%20(And%20Ovarian)%20Cancer%20Susceptibility&amp;author=W.%20D.%20Foulkes&amp;volume=18&amp;issue=5&amp;publication_year=2021&amp;pages=259-260&amp;pmid=33692540&amp;doi=10.1038/s41571-021-00491-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0017">
<cite>

Furutani, E.
, and Shimamura A.. 2017. “Germline Genetic Predisposition to Hematologic Malignancy.” Journal of Clinical Oncology
35, no. 9: 1018–1028. 10.1200/JCO.2016.70.8644.
</cite> [<a href="https://doi.org/10.1200/JCO.2016.70.8644" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5559882/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28297620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Oncology&amp;title=Germline%20Genetic%20Predisposition%20to%20Hematologic%20Malignancy&amp;author=E.%20Furutani&amp;author=A.%20Shimamura&amp;volume=35&amp;issue=9&amp;publication_year=2017&amp;pages=1018-1028&amp;pmid=28297620&amp;doi=10.1200/JCO.2016.70.8644&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0018">
<cite>

Guneri Beser, B.
, and Demirci H.. 2024. “Bilateral Choroidal Melanoma at Presentation in a Patient With Myotonic Dystrophy: Case Report and Review of the Literature.” Canadian Journal of Ophthalmology
59: e858–e860. 10.1016/j.jcjo.2024.05.009.
</cite> [<a href="https://doi.org/10.1016/j.jcjo.2024.05.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38815958/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Canadian%20Journal%20of%20Ophthalmology&amp;title=Bilateral%20Choroidal%20Melanoma%20at%20Presentation%20in%20a%20Patient%20With%20Myotonic%20Dystrophy:%20Case%20Report%20and%20Review%20of%20the%20Literature&amp;author=B.%20Guneri%20Beser&amp;author=H.%20Demirci&amp;volume=59&amp;publication_year=2024&amp;pages=e858-e860&amp;pmid=38815958&amp;doi=10.1016/j.jcjo.2024.05.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0019">
<cite>

Gupta, M. P.
, Lane A. M., DeAngelis M. M., et al. 2015. “Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.” JAMA Ophthalmology
133, no. 8: 881–887. 10.1001/jamaophthalmol.2015.1119.
</cite> [<a href="https://doi.org/10.1001/jamaophthalmol.2015.1119" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25974357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Ophthalmology&amp;title=Clinical%20Characteristics%20of%20Uveal%20Melanoma%20in%20Patients%20With%20Germline%20BAP1%20Mutations&amp;author=M.%20P.%20Gupta&amp;author=A.%20M.%20Lane&amp;author=M.%20M.%20DeAngelis&amp;volume=133&amp;issue=8&amp;publication_year=2015&amp;pages=881-887&amp;pmid=25974357&amp;doi=10.1001/jamaophthalmol.2015.1119&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0020">
<cite>

Hajkova, N.
, Hojny J., Nemejcova K., et al. 2018. “Germline Mutation in the <em>TP53</em> Gene in Uveal Melanoma.” Scientific Reports
8, no. 1: 7618. 10.1038/s41598-018-26040-0.
</cite> [<a href="https://doi.org/10.1038/s41598-018-26040-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5955881/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29769598/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Germline%20Mutation%20in%20the%20TP53%20Gene%20in%20Uveal%20Melanoma&amp;author=N.%20Hajkova&amp;author=J.%20Hojny&amp;author=K.%20Nemejcova&amp;volume=8&amp;issue=1&amp;publication_year=2018&amp;pages=7618&amp;pmid=29769598&amp;doi=10.1038/s41598-018-26040-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0021">
<cite>

Hanson, H.
, Astiazaran‐Symonds E., Amendola L. M., et al. 2023. “Management of Individuals With Germline Pathogenic/Likely Pathogenic Variants in <em>CHEK2</em>: A Clinical Practice Resource of the American College of Medical Genetics and Genomics (ACMG).” Genetics in Medicine
25, no. 10: 100870. 10.1016/j.gim.2023.100870.
</cite> [<a href="https://doi.org/10.1016/j.gim.2023.100870" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10623578/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37490054/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genetics%20in%20Medicine&amp;title=Management%20of%20Individuals%20With%20Germline%20Pathogenic/Likely%20Pathogenic%20Variants%20in%20CHEK2:%20A%20Clinical%20Practice%20Resource%20of%20the%20American%20College%20of%20Medical%20Genetics%20and%20Genomics%20(ACMG)&amp;author=H.%20Hanson&amp;author=E.%20Astiazaran%E2%80%90Symonds&amp;author=L.%20M.%20Amendola&amp;volume=25&amp;issue=10&amp;publication_year=2023&amp;pages=100870&amp;pmid=37490054&amp;doi=10.1016/j.gim.2023.100870&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0022">
<cite>

Hearle, N.
, Damato B. E., Humphreys J., et al. 2003. “Contribution of Germline Mutations in <em>BRCA2</em>, <em>P16</em>
<sup>
INK4A
</sup>, <em>P14</em>
<sup>
ARF
</sup> and <em>P15</em> to Uveal Melanoma.” Investigative Ophthalmology &amp; Visual Science
44, no. 2: 458–462. 10.1167/iovs.02-0026.
</cite> [<a href="https://doi.org/10.1167/iovs.02-0026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12556369/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Investigative%20Ophthalmology%20&amp;%20Visual%20Science&amp;title=Contribution%20of%20Germline%20Mutations%20in%20BRCA2,%20P16%20INK4A%20,%20P14%20ARF%20and%20P15%20to%20Uveal%20Melanoma&amp;author=N.%20Hearle&amp;author=B.%20E.%20Damato&amp;author=J.%20Humphreys&amp;volume=44&amp;issue=2&amp;publication_year=2003&amp;pages=458-462&amp;pmid=12556369&amp;doi=10.1167/iovs.02-0026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0023">
<cite>

Heikkinen, K.
, Rapakko K., Karppinen S. M., et al. 2006. “
<em>RAD50</em> and <em>NBS1</em> Are Breast Cancer Susceptibility Genes Associated With Genomic Instability.” Carcinogenesis
27, no. 8: 1593–1599. 10.1093/carcin/bgi360.
</cite> [<a href="https://doi.org/10.1093/carcin/bgi360" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3006189/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16474176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Carcinogenesis&amp;title=RAD50%20and%20NBS1%20Are%20Breast%20Cancer%20Susceptibility%20Genes%20Associated%20With%20Genomic%20Instability&amp;author=K.%20Heikkinen&amp;author=K.%20Rapakko&amp;author=S.%20M.%20Karppinen&amp;volume=27&amp;issue=8&amp;publication_year=2006&amp;pages=1593-1599&amp;pmid=16474176&amp;doi=10.1093/carcin/bgi360&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0024">
<cite>

Huang, K. L.
, Mashl R. J., Wu Y., et al. 2018. “Pathogenic Germline Variants in 10,389 Adult Cancers.” Cell
173, no. 2: 355–370. 10.1016/j.cell.2018.03.039.
</cite> [<a href="https://doi.org/10.1016/j.cell.2018.03.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5949147/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29625052/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Pathogenic%20Germline%20Variants%20in%2010,389%20Adult%20Cancers&amp;author=K.%20L.%20Huang&amp;author=R.%20J.%20Mashl&amp;author=Y.%20Wu&amp;volume=173&amp;issue=2&amp;publication_year=2018&amp;pages=355-370&amp;pmid=29625052&amp;doi=10.1016/j.cell.2018.03.039&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0025">
<cite>

Iscovich, J.
, Abdulrazik M., Cour C., Fischbein A., Pe'er J., and Goldgar D. E.. 2002. “Prevalence of the <em>BRCA2</em> 6174 Del T Mutation in Israeli Uveal Melanoma Patients.” International Journal of Cancer
98, no. 1: 42–44. 10.1002/ijc.10155.
</cite> [<a href="https://doi.org/10.1002/ijc.10155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11857383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Cancer&amp;title=Prevalence%20of%20the%20BRCA2%206174%20Del%20T%20Mutation%20in%20Israeli%20Uveal%20Melanoma%20Patients&amp;author=J.%20Iscovich&amp;author=M.%20Abdulrazik&amp;author=C.%20Cour&amp;author=A.%20Fischbein&amp;author=J.%20Pe'er&amp;volume=98&amp;issue=1&amp;publication_year=2002&amp;pages=42-44&amp;pmid=11857383&amp;doi=10.1002/ijc.10155&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0026">
<cite>

Johansson, P. A.
, Palmer J. M., McGrath L., et al. 2025. “Germline Variants in Patients Affected by Both Uveal and Cutaneous Melanoma.” Pigment Cell &amp; Melanoma Research
38, no. 1: e13199. 10.1111/pcmr.13199.
</cite> [<a href="https://doi.org/10.1111/pcmr.13199" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11681841/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39315505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pigment%20Cell%20&amp;%20Melanoma%20Research&amp;title=Germline%20Variants%20in%20Patients%20Affected%20by%20Both%20Uveal%20and%20Cutaneous%20Melanoma&amp;author=P.%20A.%20Johansson&amp;author=J.%20M.%20Palmer&amp;author=L.%20McGrath&amp;volume=38&amp;issue=1&amp;publication_year=2025&amp;pages=e13199&amp;pmid=39315505&amp;doi=10.1111/pcmr.13199&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0027">
<cite>

Johansson, P. A.
, Stark A., Palmer J. M., et al. 2019. “Prolonged Stable Disease in a Uveal Melanoma Patient With Germline <em>MBD4</em> Nonsense Mutation Treated With Pembrolizumab and Ipilimumab.” Immunogenetics
71, no. 5–6: 433–436. 10.1007/s00251-019-01108-x.
</cite> [<a href="https://doi.org/10.1007/s00251-019-01108-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30714079/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunogenetics&amp;title=Prolonged%20Stable%20Disease%20in%20a%20Uveal%20Melanoma%20Patient%20With%20Germline%20MBD4%20Nonsense%20Mutation%20Treated%20With%20Pembrolizumab%20and%20Ipilimumab&amp;author=P.%20A.%20Johansson&amp;author=A.%20Stark&amp;author=J.%20M.%20Palmer&amp;volume=71&amp;issue=5%E2%80%936&amp;publication_year=2019&amp;pages=433-436&amp;pmid=30714079&amp;doi=10.1007/s00251-019-01108-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0028">
<cite>

Kannengiesser, C.
, Avril M. F., Spatz A., Laud K., Lenoir G. M., and Bressac‐de‐Paillerets B.. 2003. “
<em>CDKN2A</em> as a Uveal and Cutaneous Melanoma Susceptibility Gene.” Genes, Chromosomes &amp; Cancer
38, no. 3: 265–268. 10.1002/gcc.10286.
</cite> [<a href="https://doi.org/10.1002/gcc.10286" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14506702/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes,%20Chromosomes%20&amp;%20Cancer&amp;title=CDKN2A%20as%20a%20Uveal%20and%20Cutaneous%20Melanoma%20Susceptibility%20Gene&amp;author=C.%20Kannengiesser&amp;author=M.%20F.%20Avril&amp;author=A.%20Spatz&amp;author=K.%20Laud&amp;author=G.%20M.%20Lenoir&amp;volume=38&amp;issue=3&amp;publication_year=2003&amp;pages=265-268&amp;pmid=14506702&amp;doi=10.1002/gcc.10286&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0029">
<cite>

Karczewski, K. J.
, Francioli L. C., Tiao G., et al. 2020. “The Mutational Constraint Spectrum Quantified From Variation in 141,456 Humans.” Nature
581, no. 7809: 434–443. 10.1038/s41586-020-2308-7.
</cite> [<a href="https://doi.org/10.1038/s41586-020-2308-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7334197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32461654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=The%20Mutational%20Constraint%20Spectrum%20Quantified%20From%20Variation%20in%20141,456%20Humans&amp;author=K.%20J.%20Karczewski&amp;author=L.%20C.%20Francioli&amp;author=G.%20Tiao&amp;volume=581&amp;issue=7809&amp;publication_year=2020&amp;pages=434-443&amp;pmid=32461654&amp;doi=10.1038/s41586-020-2308-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0030">
<cite>

Kiiski, J. I.
, Pelttari L. M., Khan S., et al. 2014. “Exome Sequencing Identifies FANCM as a Susceptibility Gene for Triple‐Negative Breast Cancer.” Proceedings of the National Academy of Sciences of the United States of America
111, no. 42: 15172–15177. 10.1073/pnas.1407909111.
</cite> [<a href="https://doi.org/10.1073/pnas.1407909111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4210278/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25288723/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20of%20the%20United%20States%20of%20America&amp;title=Exome%20Sequencing%20Identifies%20FANCM%20as%20a%20Susceptibility%20Gene%20for%20Triple%E2%80%90Negative%20Breast%20Cancer&amp;author=J.%20I.%20Kiiski&amp;author=L.%20M.%20Pelttari&amp;author=S.%20Khan&amp;volume=111&amp;issue=42&amp;publication_year=2014&amp;pages=15172-15177&amp;pmid=25288723&amp;doi=10.1073/pnas.1407909111&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0031">
<cite>

Kiiski, J. I.
, Tervasmäki A., Pelttari L. M., et al. 2017. “FANCM Mutation c.5791C&gt;T Is a Risk Factor for Triple‐Negative Breast Cancer in the Finnish Population.” Breast Cancer Research and Treatment
166, no. 1: 217–226. 10.1007/s10549-017-4388-0.
</cite> [<a href="https://doi.org/10.1007/s10549-017-4388-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5645429/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28702895/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Research%20and%20Treatment&amp;title=FANCM%20Mutation%20c.5791C&gt;T%20Is%20a%20Risk%20Factor%20for%20Triple%E2%80%90Negative%20Breast%20Cancer%20in%20the%20Finnish%20Population&amp;author=J.%20I.%20Kiiski&amp;author=A.%20Tervasm%C3%A4ki&amp;author=L.%20M.%20Pelttari&amp;volume=166&amp;issue=1&amp;publication_year=2017&amp;pages=217-226&amp;pmid=28702895&amp;doi=10.1007/s10549-017-4388-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0032">
<cite>

Kilpivaara, O.
, Vahteristo P., Falck J., et al. 2004. “CHEK2 Variant I157T May Be Associated With Increased Breast Cancer Risk.” International Journal of Cancer
111, no. 4: 543–547. 10.1002/ijc.20299.
</cite> [<a href="https://doi.org/10.1002/ijc.20299" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15239132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Cancer&amp;title=CHEK2%20Variant%20I157T%20May%20Be%20Associated%20With%20Increased%20Breast%20Cancer%20Risk&amp;author=O.%20Kilpivaara&amp;author=P.%20Vahteristo&amp;author=J.%20Falck&amp;volume=111&amp;issue=4&amp;publication_year=2004&amp;pages=543-547&amp;pmid=15239132&amp;doi=10.1002/ijc.20299&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0033"><cite>

Kivelä, T. T.

2014. “Incidence, Prevalence and Epidemiology of Ocular Melanoma. Ocular Melanoma: Advances in Diagnostic and Therapeutic Strategies London: Future Medicine Ltd.” pp. 20–38.</cite></li>
<li id="pcmr70041-bib-0034">
<cite>

Kopanos, C.
, Tsiolkas V., Kouris A., et al. 2019. “VarSome: The Human Genomic Variant Search Engine.” Bioinformatics
35, no. 11: 1978–1980. 10.1093/bioinformatics/bty897.
</cite> [<a href="https://doi.org/10.1093/bioinformatics/bty897" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6546127/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30376034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=VarSome:%20The%20Human%20Genomic%20Variant%20Search%20Engine&amp;author=C.%20Kopanos&amp;author=V.%20Tsiolkas&amp;author=A.%20Kouris&amp;volume=35&amp;issue=11&amp;publication_year=2019&amp;pages=1978-1980&amp;pmid=30376034&amp;doi=10.1093/bioinformatics/bty897&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0035">
<cite>

Laitman, Y.
, Niskakoski A., Bernstein‐Molho R., et al. 2024. “Phenotypes of Carriers of Two Mutated Alleles in Major Cancer Susceptibility Genes.” Breast Cancer Research and Treatment
208: 589–595. 10.1007/s10549-024-07454-z.
</cite> [<a href="https://doi.org/10.1007/s10549-024-07454-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11522137/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39102164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Research%20and%20Treatment&amp;title=Phenotypes%20of%20Carriers%20of%20Two%20Mutated%20Alleles%20in%20Major%20Cancer%20Susceptibility%20Genes&amp;author=Y.%20Laitman&amp;author=A.%20Niskakoski&amp;author=R.%20Bernstein%E2%80%90Molho&amp;volume=208&amp;publication_year=2024&amp;pages=589-595&amp;pmid=39102164&amp;doi=10.1007/s10549-024-07454-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0036">
<cite>

Li, C.
, Zhi D., Wang K., and Liu X.. 2022. “MetaRNN: Differentiating Rare Pathogenic and Rare Benign Missense SNVs and InDels Using Deep Learning.” Genome Medicine
14, no. 1: 115. 10.1186/s13073-022-01120-z.
</cite> [<a href="https://doi.org/10.1186/s13073-022-01120-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9548151/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36209109/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Medicine&amp;title=MetaRNN:%20Differentiating%20Rare%20Pathogenic%20and%20Rare%20Benign%20Missense%20SNVs%20and%20InDels%20Using%20Deep%20Learning&amp;author=C.%20Li&amp;author=D.%20Zhi&amp;author=K.%20Wang&amp;author=X.%20Liu&amp;volume=14&amp;issue=1&amp;publication_year=2022&amp;pages=115&amp;pmid=36209109&amp;doi=10.1186/s13073-022-01120-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0037">
<cite>

Lobo, J.
, Pinto C., Freitas M., et al. 2017. “Ovarian Metastasis From Uveal Melanoma With MLH1/PMS2 Protein Loss in a Patient With Germline <em>MLH1</em> Mutated Lynch Syndrome: Consequence or Coincidence?” Virchows Archiv
470, no. 3: 347–352. 10.1007/s00428-016-2052-4.
</cite> [<a href="https://doi.org/10.1007/s00428-016-2052-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27915441/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Virchows%20Archiv&amp;title=Ovarian%20Metastasis%20From%20Uveal%20Melanoma%20With%20MLH1/PMS2%20Protein%20Loss%20in%20a%20Patient%20With%20Germline%20MLH1%20Mutated%20Lynch%20Syndrome:%20Consequence%20or%20Coincidence?&amp;author=J.%20Lobo&amp;author=C.%20Pinto&amp;author=M.%20Freitas&amp;volume=470&amp;issue=3&amp;publication_year=2017&amp;pages=347-352&amp;pmid=27915441&amp;doi=10.1007/s00428-016-2052-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0038">
<cite>

MacFarlane, J.
, Seong K. C., Bisambar C., et al. 2020. “A Review of the Tumour Spectrum of Germline Succinate Dehydrogenase Gene Mutations: Beyond Phaeochromocytoma and Paraganglioma.” Clinical Endocrinology
93, no. 5: 528–538. 10.1111/cen.14289.
</cite> [<a href="https://doi.org/10.1111/cen.14289" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32686200/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Endocrinology&amp;title=A%20Review%20of%20the%20Tumour%20Spectrum%20of%20Germline%20Succinate%20Dehydrogenase%20Gene%20Mutations:%20Beyond%20Phaeochromocytoma%20and%20Paraganglioma&amp;author=J.%20MacFarlane&amp;author=K.%20C.%20Seong&amp;author=C.%20Bisambar&amp;volume=93&amp;issue=5&amp;publication_year=2020&amp;pages=528-538&amp;pmid=32686200&amp;doi=10.1111/cen.14289&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0039">
<cite>

Maniam, P.
, Zhou K., Lonergan M., Berg J. N., Goudie D. R., and Newey P. J.. 2018. “Pathogenicity and Penetrance of Germline <em>SDHA</em> Variants in Pheochromocytoma and Paraganglioma (PPGL).” Journal of the Endocrine Society
2, no. 7: 806–816. 10.1210/js.2018-00120.
</cite> [<a href="https://doi.org/10.1210/js.2018-00120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6030830/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29978154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20Endocrine%20Society&amp;title=Pathogenicity%20and%20Penetrance%20of%20Germline%20SDHA%20Variants%20in%20Pheochromocytoma%20and%20Paraganglioma%20(PPGL)&amp;author=P.%20Maniam&amp;author=K.%20Zhou&amp;author=M.%20Lonergan&amp;author=J.%20N.%20Berg&amp;author=D.%20R.%20Goudie&amp;volume=2&amp;issue=7&amp;publication_year=2018&amp;pages=806-816&amp;pmid=29978154&amp;doi=10.1210/js.2018-00120&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0040">
<cite>

McGuigan, A.
, Whitworth J., Andreou A., et al. 2022. “Multilocus Inherited Neoplasia Allele Syndrome (MINAS): An Update.” European Journal of Human Genetics
30, no. 3: 265–270. 10.1038/s41431-021-01013-6.
</cite> [<a href="https://doi.org/10.1038/s41431-021-01013-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8904543/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34983940/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Human%20Genetics&amp;title=Multilocus%20Inherited%20Neoplasia%20Allele%20Syndrome%20(MINAS):%20An%20Update&amp;author=A.%20McGuigan&amp;author=J.%20Whitworth&amp;author=A.%20Andreou&amp;volume=30&amp;issue=3&amp;publication_year=2022&amp;pages=265-270&amp;pmid=34983940&amp;doi=10.1038/s41431-021-01013-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0041">
<cite>

Morales‐Pison, S.
, Morales‐Gonzalez S., Fernandez‐Ramires R., et al. 2023. “Association of FANCM Mutations With Familial and Early‐Onset Breast Cancer Risk in a South American Population.” International Journal of Molecular Sciences
24, no. 4: 4041. 10.3390/ijms24044041.
</cite> [<a href="https://doi.org/10.3390/ijms24044041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9959766/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36835452/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=Association%20of%20FANCM%20Mutations%20With%20Familial%20and%20Early%E2%80%90Onset%20Breast%20Cancer%20Risk%20in%20a%20South%20American%20Population&amp;author=S.%20Morales%E2%80%90Pison&amp;author=S.%20Morales%E2%80%90Gonzalez&amp;author=R.%20Fernandez%E2%80%90Ramires&amp;volume=24&amp;issue=4&amp;publication_year=2023&amp;pages=4041&amp;pmid=36835452&amp;doi=10.3390/ijms24044041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0042">
<cite>

Nathan, V.
, Johansson P. A., Palmer J. M., et al. 2019. “Germline Variants in Oculocutaneous Albinism Genes and Predisposition to Familial Cutaneous Melanoma.” Pigment Cell &amp; Melanoma Research
32, no. 6: 854–863. 10.1111/pcmr.12804.
</cite> [<a href="https://doi.org/10.1111/pcmr.12804" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31233279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pigment%20Cell%20&amp;%20Melanoma%20Research&amp;title=Germline%20Variants%20in%20Oculocutaneous%20Albinism%20Genes%20and%20Predisposition%20to%20Familial%20Cutaneous%20Melanoma&amp;author=V.%20Nathan&amp;author=P.%20A.%20Johansson&amp;author=J.%20M.%20Palmer&amp;volume=32&amp;issue=6&amp;publication_year=2019&amp;pages=854-863&amp;pmid=31233279&amp;doi=10.1111/pcmr.12804&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0043">
<cite>

Nathan, V.
, Palmer J. M., Johansson P. A., et al. 2021. “Loss‐Of‐Function Variants in <em>POT1</em> Predispose to Uveal Melanoma.” Journal of Medical Genetics
58, no. 4: 234–236. 10.1136/jmedgenet-2020-107098.
</cite> [<a href="https://doi.org/10.1136/jmedgenet-2020-107098" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32907878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Medical%20Genetics&amp;title=Loss%E2%80%90Of%E2%80%90Function%20Variants%20in%20POT1%20Predispose%20to%20Uveal%20Melanoma&amp;author=V.%20Nathan&amp;author=J.%20M.%20Palmer&amp;author=P.%20A.%20Johansson&amp;volume=58&amp;issue=4&amp;publication_year=2021&amp;pages=234-236&amp;pmid=32907878&amp;doi=10.1136/jmedgenet-2020-107098&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0044">
<cite>

Nelson, A.
, and Myers K.. 1993. “Shwachman‐Diamond Syndrome.” In GeneReviews(R), edited by Adam M. P., Feldman J., and Mirzaa G. M.. Bookshelf.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/20301722/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=GeneReviews(R)&amp;author=A.%20Nelson&amp;author=K.%20Myers&amp;publication_year=1993&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0045">
<cite>

Palles, C.
, West H. D., Chew E., et al. 2022. “Germline MBD4 Deficiency Causes a Multi‐Tumor Predisposition Syndrome.” American Journal of Human Genetics
109, no. 5: 953–960. 10.1016/j.ajhg.2022.03.018.
</cite> [<a href="https://doi.org/10.1016/j.ajhg.2022.03.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9118112/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35460607/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Human%20Genetics&amp;title=Germline%20MBD4%20Deficiency%20Causes%20a%20Multi%E2%80%90Tumor%20Predisposition%20Syndrome&amp;author=C.%20Palles&amp;author=H.%20D.%20West&amp;author=E.%20Chew&amp;volume=109&amp;issue=5&amp;publication_year=2022&amp;pages=953-960&amp;pmid=35460607&amp;doi=10.1016/j.ajhg.2022.03.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0046">
<cite>

Pilarski, R.
, Byrne L., Carlo M. I., Hanson H., Cebulla C., and Abdel‐Rahman M.. 2016. “
<em>BAP1</em> Tumor Predisposition Syndrome.” In GeneReviews®, edited by Adam M. P., Feldman J., Mirzaa G. M., Pagon R. A., Wallace S. E., and Amemiya A.. University of Washington, Seattle.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/27748099/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=GeneReviews%C2%AE&amp;author=R.%20Pilarski&amp;author=L.%20Byrne&amp;author=M.%20I.%20Carlo&amp;author=H.%20Hanson&amp;author=C.%20Cebulla&amp;publication_year=2016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0047">
<cite>

Polvi, A.
, Linnankivi T., Kivelä T. T., et al. 2012. “Mutations in <em>CTC1</em>, Encoding the CTS Telomere Maintenance Complex Component 1, Cause Cerebroretinal Microangiopathy With Calcifications and Cysts.” American Journal of Human Genetics
90, no. 3: 540–549. 10.1016/j.ajhg.2012.02.002.
</cite> [<a href="https://doi.org/10.1016/j.ajhg.2012.02.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3309194/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22387016/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Human%20Genetics&amp;title=Mutations%20in%20CTC1,%20Encoding%20the%20CTS%20Telomere%20Maintenance%20Complex%20Component%201,%20Cause%20Cerebroretinal%20Microangiopathy%20With%20Calcifications%20and%20Cysts&amp;author=A.%20Polvi&amp;author=T.%20Linnankivi&amp;author=T.%20T.%20Kivel%C3%A4&amp;volume=90&amp;issue=3&amp;publication_year=2012&amp;pages=540-549&amp;pmid=22387016&amp;doi=10.1016/j.ajhg.2012.02.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0048">
<cite>

Prasad, R. N.
, Gardner U. G., Yaney A., et al. 2021. “Germline BAP1 Mutation in a Family With Multi‐Generational Meningioma With Rhabdoid Features: A Case Series and Literature Review.” Frontiers in Oncology
11: 721712. 10.3389/fonc.2021.721712.
</cite> [<a href="https://doi.org/10.3389/fonc.2021.721712" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8421801/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34504799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Oncology&amp;title=Germline%20BAP1%20Mutation%20in%20a%20Family%20With%20Multi%E2%80%90Generational%20Meningioma%20With%20Rhabdoid%20Features:%20A%20Case%20Series%20and%20Literature%20Review&amp;author=R.%20N.%20Prasad&amp;author=U.%20G.%20Gardner&amp;author=A.%20Yaney&amp;volume=11&amp;publication_year=2021&amp;pages=721712&amp;pmid=34504799&amp;doi=10.3389/fonc.2021.721712&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0049">
<cite>

Rai, K.
, Pilarski R., Boru G., et al. 2017. “Germline <em>BAP1</em> Alterations in Familial Uveal Melanoma.” Genes, Chromosomes &amp; Cancer
56, no. 2: 168–174. 10.1002/gcc.22424.
</cite> [<a href="https://doi.org/10.1002/gcc.22424" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5490375/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27718540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes,%20Chromosomes%20&amp;%20Cancer&amp;title=Germline%20BAP1%20Alterations%20in%20Familial%20Uveal%20Melanoma&amp;author=K.%20Rai&amp;author=R.%20Pilarski&amp;author=G.%20Boru&amp;volume=56&amp;issue=2&amp;publication_year=2017&amp;pages=168-174&amp;pmid=27718540&amp;doi=10.1002/gcc.22424&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0050">
<cite>

Repo, P.
, Jäntti J. E., Järvinen R. S., et al. 2020. “Germline Loss‐of‐Function Variants in <em>MBD4</em> Are Rare in Finnish Patients With Uveal Melanoma.” Pigment Cell &amp; Melanoma Research
33, no. 5: 756–762. 10.1111/pcmr.12892.
</cite> [<a href="https://doi.org/10.1111/pcmr.12892" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32421892/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pigment%20Cell%20&amp;%20Melanoma%20Research&amp;title=Germline%20Loss%E2%80%90of%E2%80%90Function%20Variants%20in%20MBD4%20Are%20Rare%20in%20Finnish%20Patients%20With%20Uveal%20Melanoma&amp;author=P.%20Repo&amp;author=J.%20E.%20J%C3%A4ntti&amp;author=R.%20S.%20J%C3%A4rvinen&amp;volume=33&amp;issue=5&amp;publication_year=2020&amp;pages=756-762&amp;pmid=32421892&amp;doi=10.1111/pcmr.12892&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0051">
<cite>

Repo, P.
, Järvinen R. S., Jäntti J. E., et al. 2019. “Population‐Based Analysis of BAP1 Germline Variations in Patients With Uveal Melanoma.” Human Molecular Genetics
28, no. 14: 2415–2426. 10.1093/hmg/ddz076.
</cite> [<a href="https://doi.org/10.1093/hmg/ddz076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31058963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Human%20Molecular%20Genetics&amp;title=Population%E2%80%90Based%20Analysis%20of%20BAP1%20Germline%20Variations%20in%20Patients%20With%20Uveal%20Melanoma&amp;author=P.%20Repo&amp;author=R.%20S.%20J%C3%A4rvinen&amp;author=J.%20E.%20J%C3%A4ntti&amp;volume=28&amp;issue=14&amp;publication_year=2019&amp;pages=2415-2426&amp;pmid=31058963&amp;doi=10.1093/hmg/ddz076&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0052">
<cite>

Repo, P. E.
, Jakkula E., Hiltunen J., et al. 2024. “Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1‐Associated Genes in Finnish Patients With Uveal Melanoma.” Pigment Cell &amp; Melanoma Research
38: e13198. 10.1111/pcmr.13198.
</cite> [<a href="https://doi.org/10.1111/pcmr.13198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11681845/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39344744/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pigment%20Cell%20&amp;%20Melanoma%20Research&amp;title=Pathogenic%20Germline%20Variants%20in%20Uveal%20Melanoma%20Driver%20and%20BAP1%E2%80%90Associated%20Genes%20in%20Finnish%20Patients%20With%20Uveal%20Melanoma&amp;author=P.%20E.%20Repo&amp;author=E.%20Jakkula&amp;author=J.%20Hiltunen&amp;volume=38&amp;publication_year=2024&amp;pages=e13198&amp;pmid=39344744&amp;doi=10.1111/pcmr.13198&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0053">
<cite>

Richards, S.
, Aziz N., Bale S., et al. 2015. “Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.” Genetics in Medicine
17, no. 5: 405–424. 10.1038/gim.2015.30.
</cite> [<a href="https://doi.org/10.1038/gim.2015.30" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4544753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25741868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genetics%20in%20Medicine&amp;title=Standards%20and%20Guidelines%20for%20the%20Interpretation%20of%20Sequence%20Variants:%20A%20Joint%20Consensus%20Recommendation%20of%20the%20American%20College%20of%20Medical%20Genetics%20and%20Genomics%20and%20the%20Association%20for%20Molecular%20Pathology&amp;author=S.%20Richards&amp;author=N.%20Aziz&amp;author=S.%20Bale&amp;volume=17&amp;issue=5&amp;publication_year=2015&amp;pages=405-424&amp;pmid=25741868&amp;doi=10.1038/gim.2015.30&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0054">
<cite>

Robinson, J. T.
, Thorvaldsdottir H., Winckler W., et al. 2011. “Integrative Genomics Viewer.” Nature Biotechnology
29, no. 1: 24–26. 10.1038/nbt.1754.</cite> [<a href="https://doi.org/10.1038/nbt.1754" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3346182/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21221095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Biotechnology&amp;title=Integrative%20Genomics%20Viewer&amp;author=J.%20T.%20Robinson&amp;author=H.%20Thorvaldsdottir&amp;author=W.%20Winckler&amp;volume=29&amp;issue=1&amp;publication_year=2011&amp;pages=24-26&amp;pmid=21221095&amp;doi=10.1038/nbt.1754&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0055">
<cite>

Rodrigues, M.
, Mobuchon L., Houy A., et al. 2018. “Outlier Response to Anti‐PD1 in Uveal Melanoma Reveals Germline <em>MBD4</em> Mutations in Hypermutated Tumors.” Nature Communications
9, no. 1: 1866. 10.1038/s41467-018-04322-5.</cite> [<a href="https://doi.org/10.1038/s41467-018-04322-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5951831/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29760383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Communications&amp;title=Outlier%20Response%20to%20Anti%E2%80%90PD1%20in%20Uveal%20Melanoma%20Reveals%20Germline%20MBD4%20Mutations%20in%20Hypermutated%20Tumors&amp;author=M.%20Rodrigues&amp;author=L.%20Mobuchon&amp;author=A.%20Houy&amp;volume=9&amp;issue=1&amp;publication_year=2018&amp;pages=1866&amp;pmid=29760383&amp;doi=10.1038/s41467-018-04322-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0056">
<cite>

Saint‐Ghislain, M.
, Derrien A. C., Geoffrois L., et al. 2022. “MBD4 Deficiency Is Predictive of Response to Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma Patients.” European Journal of Cancer
173: 105–112. 10.1016/j.ejca.2022.06.033.
</cite> [<a href="https://doi.org/10.1016/j.ejca.2022.06.033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35863105/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Cancer&amp;title=MBD4%20Deficiency%20Is%20Predictive%20of%20Response%20to%20Immune%20Checkpoint%20Inhibitors%20in%20Metastatic%20Uveal%20Melanoma%20Patients&amp;author=M.%20Saint%E2%80%90Ghislain&amp;author=A.%20C.%20Derrien&amp;author=L.%20Geoffrois&amp;volume=173&amp;publication_year=2022&amp;pages=105-112&amp;pmid=35863105&amp;doi=10.1016/j.ejca.2022.06.033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0057">
<cite>

Shen, W.
, Kerr C. M., Przychozen B., et al. 2019. “Impact of Germline <em>CTC1</em> Alterations on Telomere Length in Acquired Bone Marrow Failure.” British Journal of Haematology
185, no. 5: 935–939. 10.1111/bjh.15862.
</cite> [<a href="https://doi.org/10.1111/bjh.15862" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6536344/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30891747/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Haematology&amp;title=Impact%20of%20Germline%20CTC1%20Alterations%20on%20Telomere%20Length%20in%20Acquired%20Bone%20Marrow%20Failure&amp;author=W.%20Shen&amp;author=C.%20M.%20Kerr&amp;author=B.%20Przychozen&amp;volume=185&amp;issue=5&amp;publication_year=2019&amp;pages=935-939&amp;pmid=30891747&amp;doi=10.1111/bjh.15862&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0058">
<cite>

Siitonen, H. A.
, Sotkasiira J., Biervliet M., et al. 2009. “The Mutation Spectrum in <em>RECQL4</em> Diseases.” European Journal of Human Genetics
17, no. 2: 151–158. 10.1038/ejhg.2008.154.
</cite> [<a href="https://doi.org/10.1038/ejhg.2008.154" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2986053/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18716613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Human%20Genetics&amp;title=The%20Mutation%20Spectrum%20in%20RECQL4%20Diseases&amp;author=H.%20A.%20Siitonen&amp;author=J.%20Sotkasiira&amp;author=M.%20Biervliet&amp;volume=17&amp;issue=2&amp;publication_year=2009&amp;pages=151-158&amp;pmid=18716613&amp;doi=10.1038/ejhg.2008.154&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0059">
<cite>

Singh, A. D.
, Shields C. L., De Potter P., et al. 1996. “Familial Uveal Melanoma. Clinical Observations on 56 Patients.” Archives of Ophthalmology
114, no. 4: 392–399. 10.1001/archopht.1996.01100130388005.
</cite> [<a href="https://doi.org/10.1001/archopht.1996.01100130388005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8602775/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Archives%20of%20Ophthalmology&amp;title=Familial%20Uveal%20Melanoma.%20Clinical%20Observations%20on%2056%20Patients&amp;author=A.%20D.%20Singh&amp;author=C.%20L.%20Shields&amp;author=P.%20De%20Potter&amp;volume=114&amp;issue=4&amp;publication_year=1996&amp;pages=392-399&amp;pmid=8602775&amp;doi=10.1001/archopht.1996.01100130388005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0060">
<cite>

Sinilnikova, O. M.
, Egan K. M., Quinn J. L., et al. 1999. “Germline brca2 Sequence Variants in Patients With Ocular Melanoma.” International Journal of Cancer
82, no. 3: 325–328. .
</cite> [<a href="https://doi.org/10.1002/(sici)1097-0215(19990730)82:3&amp;#x0003c;325::aid-ijc3&amp;#x0003e;3.0.co;2-g" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10399947/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Cancer&amp;title=Germline%20brca2%20Sequence%20Variants%20in%20Patients%20With%20Ocular%20Melanoma&amp;author=O.%20M.%20Sinilnikova&amp;author=K.%20M.%20Egan&amp;author=J.%20L.%20Quinn&amp;volume=82&amp;issue=3&amp;publication_year=1999&amp;pages=325-328&amp;pmid=10399947&amp;doi=10.1002/(sici)1097-0215(19990730)82:3&amp;#x0003c;325::aid-ijc3&amp;#x0003e;3.0.co;2-g&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0061">
<cite>

Sondka, Z.
, Bamford S., Cole C. G., Ward S. A., Dunham I., and Forbes S. A.. 2018. “The COSMIC Cancer Gene Census: Describing Genetic Dysfunction Across All Human Cancers.” Nature Reviews. Cancer
18, no. 11: 696–705. 10.1038/s41568-018-0060-1.
</cite> [<a href="https://doi.org/10.1038/s41568-018-0060-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6450507/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30293088/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Cancer&amp;title=The%20COSMIC%20Cancer%20Gene%20Census:%20Describing%20Genetic%20Dysfunction%20Across%20All%20Human%20Cancers&amp;author=Z.%20Sondka&amp;author=S.%20Bamford&amp;author=C.%20G.%20Cole&amp;author=S.%20A.%20Ward&amp;author=I.%20Dunham&amp;volume=18&amp;issue=11&amp;publication_year=2018&amp;pages=696-705&amp;pmid=30293088&amp;doi=10.1038/s41568-018-0060-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0062">
<cite>

Stolarova, L.
, Kleiblova P., Janatova M., et al. 2020. “CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather Than Checkmate.” Cells
9, no. 12: 2675. 10.3390/cells9122675.
</cite> [<a href="https://doi.org/10.3390/cells9122675" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7763663/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33322746/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=CHEK2%20Germline%20Variants%20in%20Cancer%20Predisposition:%20Stalemate%20Rather%20Than%20Checkmate&amp;author=L.%20Stolarova&amp;author=P.%20Kleiblova&amp;author=M.%20Janatova&amp;volume=9&amp;issue=12&amp;publication_year=2020&amp;pages=2675&amp;pmid=33322746&amp;doi=10.3390/cells9122675&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0063">
<cite>

Sulonen, A. M.
, Ellonen P., Almusa H., et al. 2011. “Comparison of Solution‐Based Exome Capture Methods for Next Generation Sequencing.” Genome Biology
12, no. 9: R94. 10.1186/gb-2011-12-9-r94.
</cite> [<a href="https://doi.org/10.1186/gb-2011-12-9-r94" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3308057/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21955854/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Biology&amp;title=Comparison%20of%20Solution%E2%80%90Based%20Exome%20Capture%20Methods%20for%20Next%20Generation%20Sequencing&amp;author=A.%20M.%20Sulonen&amp;author=P.%20Ellonen&amp;author=H.%20Almusa&amp;volume=12&amp;issue=9&amp;publication_year=2011&amp;pages=R94&amp;pmid=21955854&amp;doi=10.1186/gb-2011-12-9-r94&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0064">
<cite>

Szklarczyk, D.
, Gable A. L., Lyon D., et al. 2019. “STRING v11: Protein‐Protein Association Networks With Increased Coverage, Supporting Functional Discovery in Genome‐Wide Experimental Datasets.” Nucleic Acids Research
47, no. D1: D607–D613. 10.1093/nar/gky1131.
</cite> [<a href="https://doi.org/10.1093/nar/gky1131" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6323986/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30476243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Research&amp;title=STRING%20v11:%20Protein%E2%80%90Protein%20Association%20Networks%20With%20Increased%20Coverage,%20Supporting%20Functional%20Discovery%20in%20Genome%E2%80%90Wide%20Experimental%20Datasets&amp;author=D.%20Szklarczyk&amp;author=A.%20L.%20Gable&amp;author=D.%20Lyon&amp;volume=47&amp;issue=D1&amp;publication_year=2019&amp;pages=D607-D613&amp;pmid=30476243&amp;doi=10.1093/nar/gky1131&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0065">
<cite>

Turunen, J. A.
, Markkinen S., Wilska R., et al. 2016. “
<em>BAP1</em> Germline Mutations in Finnish Patients With Uveal Melanoma.” Ophthalmology
123, no. 5: 1112–1117. 10.1016/j.ophtha.2016.01.008.
</cite> [<a href="https://doi.org/10.1016/j.ophtha.2016.01.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26876698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmology&amp;title=BAP1%20Germline%20Mutations%20in%20Finnish%20Patients%20With%20Uveal%20Melanoma&amp;author=J.%20A.%20Turunen&amp;author=S.%20Markkinen&amp;author=R.%20Wilska&amp;volume=123&amp;issue=5&amp;publication_year=2016&amp;pages=1112-1117&amp;pmid=26876698&amp;doi=10.1016/j.ophtha.2016.01.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0066">
<cite>

Vanharanta, S.
, Buchta M., McWhinney S. R., et al. 2004. “Early‐Onset Renal Cell Carcinoma as a Novel Extraparaganglial Component of <em>SDHB</em>‐Associated Heritable Paraganglioma.” American Journal of Human Genetics
74, no. 1: 153–159. 10.1086/381054.
</cite> [<a href="https://doi.org/10.1086/381054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1181902/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14685938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Human%20Genetics&amp;title=Early%E2%80%90Onset%20Renal%20Cell%20Carcinoma%20as%20a%20Novel%20Extraparaganglial%20Component%20of%20SDHB%E2%80%90Associated%20Heritable%20Paraganglioma&amp;author=S.%20Vanharanta&amp;author=M.%20Buchta&amp;author=S.%20R.%20McWhinney&amp;volume=74&amp;issue=1&amp;publication_year=2004&amp;pages=153-159&amp;pmid=14685938&amp;doi=10.1086/381054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0067">
<cite>

Velazquez‐Martin, J. P.
, Pavlin C. J., and Simpson E. R.. 2013. “Association Between Uveal Melanoma and Myotonic Dystrophy: A Series of 3 Cases.” JAMA Ophthalmology
131, no. 2: 246–249. 10.1001/jamaophthalmol.2013.581.
</cite> [<a href="https://doi.org/10.1001/jamaophthalmol.2013.581" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23411896/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Ophthalmology&amp;title=Association%20Between%20Uveal%20Melanoma%20and%20Myotonic%20Dystrophy:%20A%20Series%20of%203%20Cases&amp;author=J.%20P.%20Velazquez%E2%80%90Martin&amp;author=C.%20J.%20Pavlin&amp;author=E.%20R.%20Simpson&amp;volume=131&amp;issue=2&amp;publication_year=2013&amp;pages=246-249&amp;pmid=23411896&amp;doi=10.1001/jamaophthalmol.2013.581&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0068">
<cite>

Villy, M. C.
, Le Ven A., Le Mentec M., et al. 2023. “Familial Uveal Melanoma and Other Tumours in 25 Families With Monoallelic Germline MBD4 Variants.” Journal of the National Cancer Institute
116: 580–587. 10.1093/jnci/djad248.</cite> [<a href="https://doi.org/10.1093/jnci/djad248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38060262/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20National%20Cancer%20Institute&amp;title=Familial%20Uveal%20Melanoma%20and%20Other%20Tumours%20in%2025%20Families%20With%20Monoallelic%20Germline%20MBD4%20Variants&amp;author=M.%20C.%20Villy&amp;author=A.%20Le%20Ven&amp;author=M.%20Le%20Mentec&amp;volume=116&amp;publication_year=2023&amp;pages=580-587&amp;pmid=38060262&amp;doi=10.1093/jnci/djad248&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0069">
<cite>

Walpole, S.
, Pritchard A. L., Cebulla C. M., et al. 2018. “Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant‐Carrying Families Worldwide.” Journal of the National Cancer Institute
110, no. 12: 1328–1341. 10.1093/jnci/djy171.
</cite> [<a href="https://doi.org/10.1093/jnci/djy171" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6292796/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30517737/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20National%20Cancer%20Institute&amp;title=Comprehensive%20Study%20of%20the%20Clinical%20Phenotype%20of%20Germline%20BAP1%20Variant%E2%80%90Carrying%20Families%20Worldwide&amp;author=S.%20Walpole&amp;author=A.%20L.%20Pritchard&amp;author=C.%20M.%20Cebulla&amp;volume=110&amp;issue=12&amp;publication_year=2018&amp;pages=1328-1341&amp;pmid=30517737&amp;doi=10.1093/jnci/djy171&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0070">
<cite>

Wang, K.
, Li M., and Hakonarson H.. 2010. “ANNOVAR: Functional Annotation of Genetic Variants From High‐Throughput Sequencing Data.” Nucleic Acids Research
38, no. 16: e164. 10.1093/nar/gkq603.
</cite> [<a href="https://doi.org/10.1093/nar/gkq603" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2938201/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20601685/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Research&amp;title=ANNOVAR:%20Functional%20Annotation%20of%20Genetic%20Variants%20From%20High%E2%80%90Throughput%20Sequencing%20Data&amp;author=K.%20Wang&amp;author=M.%20Li&amp;author=H.%20Hakonarson&amp;volume=38&amp;issue=16&amp;publication_year=2010&amp;pages=e164&amp;pmid=20601685&amp;doi=10.1093/nar/gkq603&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0071">
<cite>

Wei, J.
, Shi Z., Na R., et al. 2020. “Germline <em>HOXB13</em> G84E Mutation Carriers and Risk to Twenty Common Types of Cancer: Results From the UK Biobank.” British Journal of Cancer
123, no. 9: 1356–1359. 10.1038/s41416-020-01036-8.
</cite> [<a href="https://doi.org/10.1038/s41416-020-01036-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7591911/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32830201/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Cancer&amp;title=Germline%20HOXB13%20G84E%20Mutation%20Carriers%20and%20Risk%20to%20Twenty%20Common%20Types%20of%20Cancer:%20Results%20From%20the%20UK%20Biobank&amp;author=J.%20Wei&amp;author=Z.%20Shi&amp;author=R.%20Na&amp;volume=123&amp;issue=9&amp;publication_year=2020&amp;pages=1356-1359&amp;pmid=32830201&amp;doi=10.1038/s41416-020-01036-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcmr70041-bib-0072">
<cite>

Whitworth, J.
, Skytte A. B., Sunde L., et al. 2016. “Multilocus Inherited Neoplasia Alleles Syndrome: A Case Series and Review.” JAMA Oncology
2, no. 3: 373–379. 10.1001/jamaoncol.2015.4771.
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2015.4771" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26659639/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncology&amp;title=Multilocus%20Inherited%20Neoplasia%20Alleles%20Syndrome:%20A%20Case%20Series%20and%20Review&amp;author=J.%20Whitworth&amp;author=A.%20B.%20Skytte&amp;author=L.%20Sunde&amp;volume=2&amp;issue=3&amp;publication_year=2016&amp;pages=373-379&amp;pmid=26659639&amp;doi=10.1001/jamaoncol.2015.4771&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>
<strong>Figure S1:</strong> Overlapping study cohorts Five overlapping cohorts of Finnish patients with uveal melanoma (UM) have been used in germline variant analyses. The initial <em>BAP1</em> variant analysis of 148 patients (Turunen et al. <a href="#pcmr70041-bib-0065" class="usa-link" aria-describedby="pcmr70041-bib-0065">2016</a>) was included in the 433 patients published later (Repo et al. <a href="#pcmr70041-bib-0051" class="usa-link" aria-describedby="pcmr70041-bib-0051">2019</a>) and is not specified further. References to the original publications are provided below.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334930/bin/PCMR-38-0-s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">PCMR-38-0-s002.pdf</a><sup> (1.4MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><p>
<strong>Figure S2:</strong> Representative Integrative Genomics Viewer (IGV) captures exome sequencing reads with identified pathogenic (P) and likely pathogenic (LP) germline variants. (A–F) depicts multilocus variant carriers and (G–Q) single variant carriers when occurring in genes associated with dominant cancer risk. Recessive alleles are depicted when co‐occurring in the patient with another P/LP variant. Variant allele frequency (VAF) was calculated from the total sequencing depth (DP) observed in IGV and can differ from the VAF of the annotated Variant Call Format (VCF) file because of read filtering (quality, duplicate).</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334930/bin/PCMR-38-0-s003.pdf" data-ga-action="click_feat_suppl" class="usa-link">PCMR-38-0-s003.pdf</a><sup> (5.4MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p"><p>
<strong>Table S1:</strong> Genes analyzed Tumor‐associated phenotypes and cancer candidate genes were obtained from PanelApp, the Cancer Gene Census (CGC) database, and literature. Note that PanelApp phenotypes may present borderline evidence (amber) for associations with specific phenotypes and associated germline/somatic status was not distinguished. For candidate cancer genes outside the databases, a publication DOI is provided.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334930/bin/PCMR-38-0-s004.pdf" data-ga-action="click_feat_suppl" class="usa-link">PCMR-38-0-s004.pdf</a><sup> (42.2KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p"><p>
<strong>Table S2:</strong> Characteristics of 106 eligible Finnish patients with primary uveal melanoma and higher‐than‐average cancer risk at the time of diagnosis, and their disease outcome.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334930/bin/PCMR-38-0-s005.docx" data-ga-action="click_feat_suppl" class="usa-link">PCMR-38-0-s005.docx</a><sup> (17.3KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="caption p"><p>
<strong>Table S3:</strong> Variants of unknown significance (VUS) identified among Finnish patients with primary uveal melanoma and higher‐than‐average cancer risk, matching the filtering criteria. Patients identified with more than one VUS are highlighted in <strong>bold</strong>.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334930/bin/PCMR-38-0-s006.pdf" data-ga-action="click_feat_suppl" class="usa-link">PCMR-38-0-s006.pdf</a><sup> (11KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material6_reqid_"><div class="caption p"><p>
<strong>Table S4:</strong> Odds ratios (OR) for Frequent Variants Pathogenic and likely pathogenic variants observed in multiple patients were tested for enrichment in Finnish patients with uveal melanoma (UM_FIN) compared to Finnish population controls from gnomAD v2.1.1 (gnomAD_FIN).</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334930/bin/PCMR-38-0-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">PCMR-38-0-s001.pdf</a><sup> (269.8KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data are available from the corresponding author upon reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Pigment Cell &amp; Melanoma Research are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1111/pcmr.70041"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/PCMR-38-0.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (704.0 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12334930/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12334930/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12334930%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334930/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12334930/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12334930/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12334930/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12334930/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12334930/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="gpPWGMtUh98U9IBWqdV8N4H534tpfUPFl4tPgxHbKTW2e7eC0kIf6DNhqQViZpTO">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
